Satoru Todo

Q: What Schools Are Affiliated With Satoru Todo

Satoru Todo is affiliated with the following schools: Hokkaido University, University of Pittsburgh

Satoru Todo's AcademicInfluence.com Rankings

Satoru Todo

Philosophy

#4158

World Rank

#6564

Historical Rank

Logic

#1679

World Rank

#2493

Historical Rank

philosophy Degrees

Satoru Todo

Biology

#5336

World Rank

#7792

Historical Rank

Cell Biology

#145

World Rank

#152

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Satoru Todo's Degrees

PhD Biology University of Tokyo
Doctorate Medicine University of Tokyo

Why Is Satoru Todo Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Satoru Todo's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Cell migration and chimerism after whole‐organ transplantation: The basis of graft acceptance (1993) (808)
FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION (1989) (791)
Hepatic resection versus transplantation for hepatocellular carcinoma. (1991) (621)
Orthotopic liver transplantation with preservation of the inferior vena cava. (1989) (565)
Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. (1994) (555)
Orthotopic liver transplantation for patients with hepatitis B virus–related liver disease (1991) (520)
Extended preservation of human liver grafts with UW solution. (1989) (379)
Living Donor Liver Transplantation for Adult Patients With Hepatocellular Carcinoma: Experience in Japan (2004) (364)
Primary nonfunction of hepatic allografts with preexisting fatty infiltration. (1989) (333)
Baboon-to-human liver transplantation (1993) (331)
Transplantation of multiple abdominal viscera. (1989) (310)
Complications of Venous Reconstruction in Human Orthotopic Liver Transplantation (1987) (305)
A pilot study of operational tolerance with a regulatory T‐cell‐based cell therapy in living donor liver transplantation (2016) (300)
Outcome Analysis of 71 Clinical Intestinal Transplantations (1995) (255)
BILIARY TRACT COMPLICATIONS IN HUMAN ORTHOTOPIC LIVER TRANSPLANTATION (1987) (249)
Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. (1998) (249)
Orthotopic liver transplantation for alcoholic cirrhosis. (1988) (245)
Pancreatic islet transplantation after upper abdominal exeriteration and liver replacement (1990) (243)
Orthotopic Liver Transplantation for Primary Sclerosing Cholangitis (1988) (243)
Abdominal Organ Cluster Transplantation for the Treatment of Upper Abdominal Malignancies (1989) (240)
Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation. (1998) (239)
The spectrum of portal vein thrombosis in liver transplantation. (1991) (231)
Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. (1988) (228)
Pathology of human intestinal transplantation. (1996) (228)
Epstein–Barr virus‐encoded poly(A)− RNA supports Burkitt's lymphoma growth through interleukin‐10 induction (2000) (228)
Liver, Kidney, and Thoracic Organ Transplantation Under FK 506 (1990) (224)
FK 506 for human liver, kidney, and pancreas transplantation (1989) (223)
Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma (2005) (222)
Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event? (1989) (220)
EFFECT OF COLD ISCHEMIA TIME ON THE EARLY OUTCOME OF HUMAN HEPATIC ALLOGRAFTS PRESERVED WITH UW SOLUTION (1991) (219)
Current status of intestinal transplantation in children. (1998) (214)
Intestinal transplantation in composite visceral grafts or alone. (1992) (212)
Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. (2004) (209)
Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. (1988) (204)
Neurologic complications of FK 506. (1991) (196)
Refinements in the surgical technique of liver transplantation. (1985) (194)
Living donor liver transplantation in adults: Outcome in Japan (2000) (193)
Adverse effects associated with the use of FK 506. (1991) (190)
The novel antioxidant edaravone: from bench to bedside. (2008) (189)
The many faces of multivisceral transplantation. (1991) (185)
Number of Lymph Node Metastases Is a Significant Prognostic Factor in Intrahepatic Cholangiocarcinoma (2005) (177)
Analysis of donor criteria for the prediction of outcome in clinical liver transplantation. (1987) (173)
Liver transplantation in the treatment of primary liver cancer. (1990) (170)
Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer (2006) (168)
Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation (1997) (164)
Liver transplantation in the treatment of bleeding esophageal varices. (1988) (160)
Autoinhibitory Regulation of p73 by ΔNp73 To Modulate Cell Survival and Death through a p73-Specific Target Element within the ΔNp73 Promoter (2002) (159)
Involvement of Macrophage Migration Inhibitory Factor (MIF) in the Mechanism of Tumor Cell Growth (1998) (157)
Long survival in rats after multivisceral versus isolated small-bowel allotransplantation under FK 506. (1991) (157)
Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. (2010) (156)
Assessment of five-year experience with abdominal organ cluster transplantation. (1995) (153)
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. (1991) (152)
The antibody crossmatch in liver transplantation. (1986) (151)
CADAVERIC SMALL BOWEL AND SMALL BOWEL‐LIVER TRANSPLANTATION IN HUMANS 1,2 (1992) (149)
Liver transplantation across ABO blood groups. (1986) (148)
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. (1988) (147)
Clinical intestinal transplantation. (1993) (146)
Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. (1992) (146)
Clinical intestinal transplantation: new perspectives and immunologic considerations. (1998) (139)
An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. (2000) (139)
Three years clinical experience with intestinal transplantation. (1994) (137)
Pharmacokinetics of FK 506: preclinical and clinical studies. (1990) (132)
Orthotopic liver transplantation for urea cycle enzyme deficiency (1992) (130)
Alveolar echinococcosis: MR findings in the liver. (2003) (130)
Hepatic resection and transplantation for peripheral cholangiocarcinoma. (1997) (130)
肝,腎,およびすい臓移植のためのFK506 (1989) (129)
Macrophage Migration Inhibitory Factor (MIF) (1996) (127)
Liver transplantation before 1 year of age. (1987) (126)
Evolution of hepatitis B virus liver disease after hepatic replacement. Practical and theoretical considerations. (1990) (122)
Treatment of hepatic epithelioid hemangioendothelioma with liver transplantation (1988) (122)
Humoral Responses to Peptides Correlate with Overall Survival in Advanced Cancer Patients Vaccinated with Peptides Based on Pre-existing, Peptide-Specific Cellular Responses (2004) (119)
THE ADVERSE IMPACT ON LIVER TRANSPLANTATION OF USING POSITIVE CYTOTOXIC CROSSMATCH DONORS 1, 2 (1992) (118)
Somatic mutations of the APC gene in primary breast cancers. (2000) (118)
Hepatic artery in liver transplantation. (1987) (116)
The side effects of FK 506 in humans. (1990) (115)
Quality of life after small intestinal transplantation and among home parenteral nutrition patients. (1998) (115)
THE EFFECT OF GRAFT FUNCTION ON FK506 PLASMA LEVELS, DOSAGES, AND RENAL FUNCTION, WITH PARTICULAR REFERENCE TO THE LIVER (1991) (110)
CONVERSION OF LIVER ALLOGRAFT RECIPIENTS FROM CYCLOSPORINE TO FK506 IMMUNOSUPPRESSIVE THERAPY—A CLINICOPATHOLOGIC STUDY OF 96 PATIENTS (1992) (110)
Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas. (1998) (110)
SMALL INTESTINAL TRANSPLANTATION IN HUMANS WITH OR WITHOUT THE COLON1,2 (1994) (108)
Effect of hepatic dysfunction and T tube clamping on FK 506 pharmacokinetics and trough concentrations. (1990) (106)
Childbearing after liver transplantation. (1990) (105)
Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice. (2005) (105)
Liver transplantation for polycystic liver disease. (1990) (105)
The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation. (1996) (104)
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. (1990) (104)
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. (1990) (103)
Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): Up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer (2007) (102)
The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma (2009) (101)
Recurrence Patterns After Hepatectomy of Hepatocellular Carcinoma: Implication of Milan Criteria Utilization (2009) (99)
Endotoxemia and human liver transplantation. (1989) (99)
A Human Anti‐CD40 Monoclonal Antibody, 4D11, for Kidney Transplantation in Cynomolgus Monkeys: Induction and Maintenance Therapy (2009) (98)
TRIM40 promotes neddylation of IKKγ and is downregulated in gastrointestinal cancers. (2011) (97)
Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter. (2002) (97)
A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. (1996) (97)
Frequent achievement of a drug-free state after orthotopic liver transplantation. (1993) (96)
Venous jump grafts for liver transplantation in patients with portal vein thrombosis. (1989) (96)
Excisional therapy for benign hepatic lesions. (1990) (94)
Markers for microvascular invasion in hepatocellular carcinoma: Where do we stand? (2011) (94)
Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis (2001) (94)
Adenoviral infections in pediatric liver transplant recipients. (1987) (93)
Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway. (2005) (93)
Immunopathology of antibodies as effectors of orthotopic liver allograft rejection. (1992) (90)
ENDOTOXAEMIA, PULMONARY COMPLICATIONS, AND THROMBOCYTOPENIA IN LIVER TRANSPLANTATION (1989) (89)
Excessive portal venous inflow as a cause of allograft dysfunction in small-for-size living donor liver transplantation. (2001) (89)
Liver transplantation for Alagille's syndrome. (1993) (89)
Indocyanine green elimination test in orthotopic liver recipients (1996) (88)
AUGMENTATION OF RAT LIVER REGENERATION BY FK 506 COMPARED WITH CYCLOSPORIN (1989) (88)
Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys. (1989) (88)
Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. (1988) (88)
Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis. (2003) (87)
Analysis of surgical complications after 397 hepatic transplantations. (1990) (87)
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. (1991) (85)
The survival pathways phosphatidylinositol‐3 kinase (PI3‐K)/phosphoinositide‐dependent protein kinase 1 (PDK1)/Akt modulate liver regeneration through hepatocyte size rather than proliferation (2009) (85)
Current status of intestinal transplantation. (1994) (85)
Rejection of multivisceral allografts in rats: a sequential analysis with comparison to isolated orthotopic small-bowel and liver grafts. (1990) (84)
Liver transplantation in patients with previous portasystemic shunt. (1990) (84)
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. (1994) (83)
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. (1987) (83)
Liver transplantation in patients over sixty years of age. (2001) (83)
Hepatic resection for cystic lesions of the liver. (1993) (83)
Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart, and pancreas islet transplantation (1994) (82)
Extending indication: Role of living donor liver transplantation for hepatocellular carcinoma (2007) (81)
Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma (2011) (81)
Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. (1991) (80)
Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer. (2002) (80)
Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature (2008) (80)
Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis (2013) (80)
A Novel Fully Human Anti-CD40 Monoclonal Antibody, 4D11, for Kidney Transplantation in Cynomolgus Monkeys (2007) (79)
Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma (2008) (79)
Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. (1991) (79)
Control of Intraoperative Bleeding During Liver Resection: Analysis of a Questionnaire Sent to 231 Japanese Hospitals (2002) (79)
Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. (1995) (78)
The effects of FK 506 on renal function after liver transplantation. (1990) (78)
THE PROTECTIVE EFFECT OF FK506 PRETREATMENT AGAINST RENAL ISCHEMIA/REPERFUSION INJURY IN RATS1 (1992) (77)
Early trials with FK 506 as primary treatment in liver transplantation. (1990) (77)
SUPPRESSION OF ALLOGRAFT REJECTION WITH FK506: I. PROLONGED CARDIAC AND LIVER SURVIVAL IN RATS FOLLOWING SHORT‐COURSE THERAPY (1990) (75)
Reversal of hypersplenism following orthotopic liver transplantation. (1989) (75)
The clinical significance of the arterial ketone body ratio as an early indicator of graft viability in human liver transplantation. (1991) (73)
Kidney transplantation under FK 506 immunosuppression. (1991) (73)
Immunological evaluation of peptide vaccination for patients with gastric cancer based on pre‐existing cellular response to peptide (2003) (73)
Stromal Cell–Derived Factor-1 and CXCR4 Interaction Is Critical for Development of Transplant Arteriosclerosis (2004) (73)
Hepatic Resection and Transplantation for Peripheral Cholangiocarcinoma (1997) (72)
She4p/Dim1p interacts with the motor domain of unconventional myosins in the budding yeast, Saccharomyces cerevisiae. (2003) (71)
Abdominal Multivisceral Transplantation (1995) (71)
Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium (2013) (71)
Expanded living‐donor liver transplantation criteria for patients with hepatocellular carcinoma based on the Japanese nationwide survey: the 5‐5‐500 rule ‐ a retrospective study (2019) (71)
Cholangiocarcinoma and sclerosing cholangitis: clinical characteristics and effect on survival after liver transplantation. (1993) (70)
GRAFT‐VERSUS‐HOST DISEASE AFTER BROWN NORWAY‐TO‐LEWIS AND LEWIS‐TO‐BROWN NORWAY RAT INTESTINAL TRANSPLANTATION UNDER FK506 (1993) (70)
Control of hepatocyte adhesion and function on self-organized honeycomb-patterned polymer film (2006) (70)
Liver transplantation without the use of blood products. (1994) (69)
Infectious complications after small bowel transplantation in adults: an update. (1996) (69)
Effects of synthetic antifreeze glycoprotein analogue on islet cell survival and function during cryopreservation. (2006) (69)
Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506 (1991) (68)
The Biological Basis of and Strategies for Clinical Xenotransplantation (1994) (68)
Proteomic signature corresponding to alpha fetoprotein expression in liver cancer cells (2004) (67)
Epstein Barr virus associated posttransplant lymphoproliferative disease after intestinal transplantation. (1996) (66)
Prevention of lethal acute hepatic failure by antimacrophage migration inhibitory factor antibody in mice treated with bacille calmette‐guerin and lipopolysaccharide (1999) (65)
Logistics and technique for combined hepatic-intestinal retrieval. (1992) (65)
Indications for pediatric liver transplantation. (1987) (65)
Orthotopic liver transplantation in dogs receiving FK-506. (1987) (65)
HEPATIC ARTERY PSEUDOANEURYSM LIGATION AFTER ORTHOTOPIC LIVER TRANSPLANTATION—A REPORT OF 7 CASES (1992) (64)
BlotGlycoABC™, an Integrated Glycoblotting Technique for Rapid and Large Scale Clinical Glycomics *S (2008) (64)
Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma (2012) (64)
Biopharmaceutical aspects of FK-506. (1987) (64)
Cancer arising in a choledochal cyst in a 12-year-old girl. (1990) (64)
Renal transplantation in baboons under FK 506. (1989) (63)
Hepatic artery reconstruction for hepatic artery thrombosis after orthotopic liver transplantation. (1990) (63)
Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma. (2010) (63)
Postnatal management for prenatally diagnosed choledochal cysts. (2004) (63)
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. (1991) (63)
Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer (2012) (63)
Acute invasive sinusitis due to Trichoderma longibrachiatum in a liver and small bowel transplant recipient. (1998) (62)
The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer (2005) (62)
Randomised trialomania? The multicentre liver transplant trials of tacrolimus (1995) (62)
Lipid peroxidation during ischemia depends on ischemia time in warm ischemia and reperfusion of rat liver. (2005) (61)
Sequential Observation of Liver Cell Regeneration after Massive Hepatic Necrosis in Auxiliary Partial Orthotopic Liver Transplantation (2000) (61)
Physical Interaction of p73 with c-Myc and MM1, a c-Myc-binding Protein, and Modulation of the p73 Function* (2002) (61)
First clinical trial of cancer vaccine therapy with artificially synthesized helper/ killer‐hybrid epitope long peptide of MAGE‐A4 cancer antigen (2012) (61)
Mutational analysis of p51A/TAp63γ, a p53 homolog, in non-small cell lung cancer and breast cancer (1999) (61)
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. (1987) (60)
Liver transplantation for the Budd-Chiari syndrome. (1976) (60)
FK 506: a new therapeutic agent for severe recalcitrant psoriasis. (1991) (60)
Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice. (2002) (59)
Temporary end to side portacaval shunt in orthotopic hepatic transplantation in humans. (1993) (59)
Percutaneous transluminal angioplasty for hepatic artery stenosis after living donor liver transplantation (2006) (59)
Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer–Initiating Cells and Is a Potent Target of Immunotherapy (2016) (58)
The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients (2008) (58)
Prospects of clinical xenotransplantation. (1994) (58)
Attenuation of ischemic liver injury by augmentation of endogenous adenosine. (1997) (58)
Hepatotrophic effects of FK506 in dogs. (1991) (57)
TREATMENT OF CYCLOSPORIN-INDUCED HAEMOLYTIC URAEMIC SYNDROME WITH FK506 (1989) (56)
Right trisegmentectomy with a synthetic vena cava graft. (1988) (55)
Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review. (1991) (54)
Liver transplantation for fulminant hepatic failure. (1985) (54)
Preventing hypoxia/reoxygenation damage to hepatocytes by p66(shc) ablation: up-regulation of anti-oxidant and anti-apoptotic proteins. (2008) (54)
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. (1991) (54)
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. (1991) (54)
UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination (2005) (53)
Liver transplantation: an unfinished product. (1989) (53)
A novel leflunomide derivative, FK778, for immunosuppression after kidney transplantation in dogs. (2002) (53)
ASKP1240, a Fully Human Anti‐CD40 Monoclonal Antibody, Prolongs Pancreatic Islet Allograft Survival in Nonhuman Primates (2013) (52)
N-glycan alterations are associated with drug resistance in human hepatocellular carcinoma (2007) (52)
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. (1990) (52)
Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. (1993) (52)
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. (1987) (52)
Cytomegalovirus infection after intestinal transplantation in children. (1997) (51)
Pulmonary resection for metastases from hepatocellular carcinoma: factors influencing prognosis. (2006) (51)
Pediatric liver transplantation. (1987) (50)
Immunological evaluation of personalized peptide vaccination in combination with a 5‐fluorouracil derivative (TS‐1) for advanced gastric or colorectal carcinoma patients (2007) (50)
A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patients (2004) (49)
Irreducible indirect inguinal hernia containing uterus, ovaries, and Fallopian tubes (2012) (49)
Protective role of nitric oxide in ischemia and reperfusion injury of the liver (1999) (49)
Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis. (2003) (49)
Two-year experience with FK 506 in pediatric patients. (1993) (49)
Liver transplantation in older patients. (1987) (49)
Corrective treatment and anatomic considerations for laparoscopic cholecystectomy injuries. (1994) (49)
MUCOSAL DAMAGE AND RECOVERY OF THE INTESTINE AFTER PROLONGED PRESERVATION AND TRANSPLANTATION IN DOGS1 (2001) (48)
Pharmacokinetics of FK506 in Liver Transplant Recipients After Continuous Intravenous Infusion (1993) (48)
Toxicology of FK-506 in the Lewis rat. (1987) (48)
Orthotopic liver transplantation for ornithine transcarbamylase deficiency with hyperammonemic encephalopathy. (1995) (47)
Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from 99mTc‐GSA scintigraphy (2008) (46)
Three‐dimensional computed tomography scan analysis of hepatic vasculatures in the donor liver for living donor liver transplantation (2010) (46)
How to prevent and manage biliary complications in living donor liver transplantation? (2005) (46)
Long-term results of hepatectomy for patients with alveolar echinococcosis: a single-center experience. (2011) (46)
Efficacy of preoperative radiotherapy to portal vein tumor thrombus in the main trunk or first branch in patients with hepatocellular carcinoma (2007) (46)
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice. (2012) (46)
Identification of the p33(ING1)-regulated genes that include cyclin B1 and proto-oncogene DEK by using cDNA microarray in a mouse mammary epithelial cell line NMuMG. (2002) (46)
Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs. (2000) (45)
Pathologic observations in human allograft recipients treated with FK 506. (1990) (45)
Late mortality and morbidity after liver transplantation. (1987) (45)
A Radical Scavenger, Edaravone, Protects Canine Kidneys from Ischemia-Reperfusion Injury after 72 Hours of Cold Preservation and Autotransplantation (2005) (45)
Intracellular localization of mesothelin predicts patient prognosis of extrahepatic bile duct cancer. (2012) (44)
Graft-versus-host disease after liver and small bowel transplantation in a child. (1997) (44)
Liquid chromatographic method for the determination of ganciclovir and/or acyclovir in human plasma using pulsed amperometric detection. (2002) (44)
The hepatotropic influence of cyclosporine. (1990) (44)
Clinicopathologic factors affecting patient survival and tumor recurrence after orthotopic liver transplantation for hepatocellular carcinoma. (1991) (44)
Comparison of various lazaroid compounds for protection against ischemic liver injury. (1997) (44)
Proteomic profiling reveals the prognostic value of adenomatous polyposis coli–end‐binding protein 1 in hepatocellular carcinoma (2008) (43)
The novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats. (2008) (43)
Use of quantitative PCR to predict onset of Epstein-Barr viral infection and post-transplant lymphoproliferative disease after intestinal transplantation in children. (1996) (43)
An improved technique for isolated perfusion of rat livers and an evaluation of perfusates. (1992) (43)
The question of FK 506 nephrotoxicity after liver transplantation. (1991) (43)
Effect of FK506 on insulin secretion in normal dogs. (1992) (43)
Does the Permanent Portacaval Shunt for a Small‐for‐Size Graft in a Living Donor Liver Transplantation Do More Harm Than Good? (2007) (42)
Experience with primary liver transplantation across ABO blood groups. (1987) (42)
Changes in renal function after liver transplantation under FK 506. (1991) (42)
Monitoring and treatment of intestinal allograft rejection in humans. (1993) (42)
Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers (2000) (41)
Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination (2010) (41)
Expessive dysphasia possibly related to FK506 in two liver transplant recipients (1990) (41)
Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas. (1999) (41)
[TNM classification--pediatric tumors]. (1998) (41)
Assay of FK 506 in plasma. (1990) (40)
Can adenine nucleotides predict primary nonfunction of the human liver homograft? (1994) (40)
Replacement of donor lymphoid tissue in human small bowel transplants under FK 506 immunosuppression (1991) (40)
Glucose Metabolism during Liver Transplantation in Dogs (1987) (40)
A novel method for faster formation of rat liver cell spheroids. (2002) (40)
Liver transplantation in patients with situs inversus. (1990) (39)
Use of DNA amplification for diagnosis of cytomegalovirus enteritis after intestinal transplantation. (1997) (39)
FK506 and pregnancy in liver transplant patients. (1993) (38)
A novel hydroxyl radical scavenger, nicaraven, protects the liver from warm ischemia and reperfusion injury. (2000) (38)
IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBPδ (2007) (38)
Nutritional management of intestinal transplant recipients. (1993) (38)
Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies (2003) (37)
Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 and hTERT as cell sources for liver cell-based therapy. (2008) (37)
Establishment of Immortalized Human Hepatocytes by Introduction of HPV16 E6/E7 and hTERT as Cell Sources for Liver Cell-Based Therapy (2008) (37)
Comparison of University of Wisconsin, Euro-Collins, and lactated Ringer's solutions in rat small bowel preservation for orthotopic small bowel transplantation. (1994) (37)
Intestinal motility after small bowel transplantation. (1998) (37)
Lazaroid U-74389G for 48-hour canine liver preservation. (1996) (37)
The impact of anatomical resection for hepatocellular carcinoma that meets the milan criteria (2010) (37)
Prolongation of Pig‐to‐Dog Renal Xenograft Survival by Modification of the Inflammatory Mediator Response (1987) (37)
Induction of liver, heart, and multivisceral graft acceptance with a short course of FK 506. (1990) (36)
Early tolerance in pediatric liver allograft recipients. (1994) (36)
Negative autoregulation of p73 and p53 by DeltaNp73 in regulating differentiation and survival of human neuroblastoma cells. (2003) (36)
Dipyridamole protects the liver against warm ischemia and reperfusion injury. (2004) (35)
A simplified technique for revascularization of homografts of the liver with a variant right hepatic artery from the superior mesenteric artery. (1985) (35)
FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood (1990) (35)
Acute pancreatitis after liver transplantation: incidence and contributing factors (1995) (35)
Treatment of upper abdominal malignancies with organ cluster procedures. (1990) (35)
Accidental transplantation of malignant tumor from a donor to multiple recipients. (1987) (34)
Comparison of superoxide dismutase, allopurinol, coenzyme Q10, and glutathione for the prevention of warm ischemic injury. (1990) (34)
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. (1995) (34)
Effects of combined administration of FK 506 and the purine biosynthesis inhibitors mizoribine or mycophenolic acid on lymphocyte DNA synthesis and T cell activation molecule expression in human mixed lymphocyte cultures. (1993) (34)
Preoperative Evaluation of Hepatic Vasculature by Three-Dimensional Computed Tomographyin Patients Undergoing Hepatectomy (2006) (34)
Antibody mediated rejection of human liver allografts: transplantation across ABO blood group barriers. (1989) (34)
Hypothermic preservation effect on mammalian cells of type III antifreeze proteins from notched-fin eelpout. (2008) (34)
Use of FK 506 in pediatric patients. (1991) (34)
Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients. (2010) (34)
The influence of donor and recipient strains in isolated small bowel transplantation in rats. (1994) (34)
Successful orthotopic small bowel transplantation with short-term FK 506 immunosuppressive therapy. (1990) (34)
FK 506 versus cyclosporine in pediatric liver transplantation. (1991) (34)
Hydrogen sulfide augments survival signals in warm ischemia and reperfusion of the mouse liver (2015) (33)
Evolution of immunosuppression in liver transplantation: contribution of cyclosporine. (2004) (33)
Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483. (1998) (32)
Control of Allograft Rejection by Applying a Novel Nuclear Factor-&kgr;B Inhibitor, Dehydroxymethylepoxyquinomicin (2006) (32)
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation. (1990) (32)
AFP mRNA Detected in Bone Marrow by Real-Time Quantitative RT-PCR Analysis Predicts Survival and Recurrence After Curative Hepatectomy for Hepatocellular Carcinoma (2006) (32)
Liver transplantation for type I and type IV glycogen storage disease (2005) (32)
Combined treatment with TNP-470 and 5-fluorouracil effectively inhibits growth of murine colon cancer cells in vitro and liver metastasis in vivo. (2000) (32)
Transient portacaval shunt for a small‐for‐size graft in living donor liver transplantation (2007) (32)
Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. (1991) (32)
Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40. (1997) (32)
C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma (2013) (32)
Conversion of liver allograft recipients with cyclosporine related complications from cyclosporine to FK 506 (1990) (31)
Induction of donor-specific tolerance by adenovirus-mediated cd40ig gene therapy in rat liver transplantation1 (2002) (31)
Piggyback orthotopic intestinal transplantation. (1993) (31)
Dehydroxymethylepoxyquinomicin (DHMEQ), a novel NF‐kappaB inhibitor, inhibits allergic inflammation and airway remodelling in murine models of asthma (2012) (31)
Type I interferon prolongs cell cycle progression via p21WAF1/CIP1 induction in human colon cancer cells. (2007) (31)
Blocking the CD28-B7 T-cell costimulatory pathway abrogates the development of obliterative bronchiolitis in a murine heterotopic airway model. (2000) (31)
Inhibition of macrophage activation and suppression of graft rejection by DTCM-glutarimide, a novel piperidine derived from the antibiotic 9-methylstreptimidone (2011) (31)
PRELIMINARY EXPERIENCE WITH FK506 IN THORACIC TRANSPLANTATION (1991) (31)
Intestinal transplantation in children under FK 506 immunosuppression. (1993) (31)
Effect of ischemia on the canine large bowel: a comparison with the small intestine. (1996) (30)
A novel inhibitor of Rho-associated protein kinase, Y-27632, ameliorates hepatic ischemia and reperfusion injury in rats. (2003) (30)
Protective role of nitric oxide in ischemia and reperfusion injury of the liver. (1998) (30)
Liver transplantation for arteriohepatic dysplasia (Alagille's syndrome) (1992) (30)
Long‐Term Hepatic Allograft Acceptance Based on CD40 Blockade by ASKP1240 in Nonhuman Primates (2012) (30)
FK 506 as a growth control factor. (1990) (30)
Peripheral anatomic evaluation using 3D CT hepatic venography in donors: significance of peripheral venous visualization in living-donor liver transplantation. (2004) (30)
The UW solution for canine kidney preservation. Its specific effect on renal hemodynamics and microvasculature. (1989) (29)
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. (1995) (29)
Swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell lines (2007) (29)
Renal artery reconstruction for harvesting injuries in kidney transplantation with particular reference to the use of vascular allografts (1988) (29)
Factors in the Development of Liver Transplantation. (1985) (29)
Species-specific cyclosporine metabolism. (1988) (28)
Infections in adult liver transplant patients under FK 506 immunosuppression. (1991) (28)
Role of bile and bile salts on cyclosporine absorption in dogs. (1987) (28)
Quality of life after intestinal transplantation and on total parenteral nutrition. (1998) (28)
Biliary tract complications in orthotopic adult liver transplantation. (1989) (28)
Preformed lymphocytotoxic antibodies: The effects of class, titer and specificity on liver vs. heart allografts (1992) (28)
Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant. (1991) (28)
Endogenous endotoxemia during orthotopic liver transplantation in dogs. (1989) (28)
Current status of FK 506 in liver transplantation. (1991) (27)
An Unusual Complication of Choledochocholedochostomy in Orthotopic Liver Transplantation (1988) (27)
Preparation of the Honeycomb Patterned Porous Film of Biodegradable Polymer for Tissue Engineering Scaffolds (2002) (27)
Infectious complications of pediatric liver transplantation under FK 506. (1991) (27)
Graft versus host disease (GVHD) after BN to LEW compared to LEW to BN rat intestinal transplantation under FK 506 (1993) (27)
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers. (1992) (27)
Liver transplantation under cyclosporine: a decade of experience. (1991) (27)
Impact of double-filtration plasmapheresis in combination with interferon and ribavirin in living donor liver transplant recipients with hepatitis C. (2006) (27)
EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION. (1986) (27)
Management and outcome in prenatally diagnosed sacrococcygeal teratomas (2008) (26)
A clinical trial of FK 506 as primary and rescue immunosuppression in cardiac transplantation. (1991) (26)
Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation. (1988) (26)
Array comparative genomic hybridization analysis revealed four genomic prognostic biomarkers for primary gastric cancers. (2010) (26)
Risk factors for portal vein complications in pediatric living donor liver transplantation (2010) (26)
Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts. (1999) (26)
Protective effect of agiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver. (2001) (26)
Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. (1996) (25)
Effect of FK 506 on Spontaneous Diabetes in BB Rats (1990) (25)
Strategy of FK 506 therapy in liver transplant patients: effect of graft function. (1991) (25)
Hydrogen Gas Ameliorates Hepatic Reperfusion Injury After Prolonged Cold Preservation in Isolated Perfused Rat Liver. (2016) (25)
Liver transplantation for alcoholic liver disease: a consideration of reasons for and against. (1989) (25)
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. (1994) (25)
FK 506 used as rescue therapy for human liver allograft recipients. (1991) (25)
FK506: a novel immunosuppressive agent. Characteristics of binding and uptake by human lymphocytes. (1988) (24)
Comparison of UW with other solutions for liver preservation in dogs. (1989) (24)
Clinical small bowel or small bowel plus liver transplantation under FK 506. (1991) (24)
Extrinsic intestinal reinnervation after canine small bowel autotransplantation. (1998) (24)
Distribution of FK 506 in plasma lipoproteins in transplant patients. (1991) (24)
Rapid Flush Technique for Donor Hepatectomy: Safety and Efficacy of an Improved Method of Liver Recovery for Transplantation. (1988) (24)
Anti-donor regulatory T cell therapy in liver transplantation. (2017) (24)
Anatomic variability of rejection in intestinal allografts after pediatric intestinal transplantation. (1998) (23)
Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas. (2004) (23)
Liver transplantation for hereditary tyrosinemia in the presence of hepatocellular carcinoma. (1989) (23)
ATTENUATION OF ISCHEMIA AND REPERFUSION INJURY OF CANINE LIVERS BY INHIBITION OF TYPE II PHOSPHOLIPASE A2 WITH LY3297221 (2001) (23)
Infectious complications after small bowel transplantation in adults. (1994) (23)
Expressive dysphasia possibly related to FK506 in two liver transplant recipients. (1990) (23)
Age- and gender-related differences in carbohydrate concentrations of α1-acid glycoprotein variants and the effects of glycoforms on their drug-binding capacities (2002) (23)
Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin. (1991) (23)
HAMSTER TO RAT KIDNEY XENOTRANSPLANTATION EFFECTS OF FK 506, CYCLOPHOSPHAMIDE, ORGAN PERFUSION, AND COMPLEMENT INHIBITION (1995) (23)
Detection of complications after liver transplantation by technetium-99m mebrofenin hepatobiliary scintigraphy (1991) (23)
Liver transplantation for hepatocellular carcinoma: the Japanese experience (2010) (23)
Management of childhood and adolescent thyroid carcinoma: long-term follow-up and clinical characteristics. (2006) (23)
Overview of FK506 in transplantation. (1990) (23)
Pharmacokinetics of the cyclosporine-ketoconazole interaction in dogs. (1989) (23)
Delay of gastric emptying measured by 13C-acetate breath test in neurologically impaired children with gastroesophageal reflux. (2005) (22)
Effect of Gastric pH on the Bioavailability of Albendazole in Rabbits (1998) (22)
Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice. (2010) (22)
Intestinal transplantation and bacterial overgrowth in humans. (1994) (22)
Role of cyclic nucleotides in ischemia and reperfusion injury of canine livers. (2002) (22)
Amelioration of normothermic canine liver ischemia with prostacyclin. (1988) (22)
Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery (2007) (22)
COMBINED IMMUNOSUPPRESSIVE THERAPY WITH LOW DOSE FK506 AND ANTIMETABOLITES IN RAT ALLOGENEIC HEART TRANSPLANTATION (1994) (22)
Identification of Protein Kinase A Catalytic Subunit β as a Novel Binding Partner of p73 and Regulation of p73 Function* (2005) (21)
The effect of small bowel transplantation on the morphology and physiology of intestinal muscle: a comparison of autografts versus allografts in dogs. (1997) (21)
Intestinal transplantation in humans under FK 506. (1993) (21)
Studies of the hepatotrophic qualities of FK 506 and CyA. (1990) (21)
Hirschsprung's disease, acrocallosal syndrome, and congenital hydrocephalus: report of 2 patients and literature review. (2008) (21)
Efficacy of DHMEQ, a NF-&kgr;B Inhibitor, in Islet Transplantation: I. HMGB1 Suppression by DHMEQ Prevents Early Islet Graft Damage (2013) (21)
Clinical considerations in orthotopic liver transplantation. (1987) (21)
Effective Fluconazole Therapy for Liver Transplant Recipients During Continuous Hemodiafiltration (2001) (21)
Small-for-size syndrome in living-donor liver transplantation using a left lobe graft (2015) (21)
Late complications with gallbladder conduit biliary reconstruction after liver transplantation. (1989) (21)
Canine total orthotopic small bowel transplantation under FK 506. (1991) (21)
Retinoic acid-induced apoptosis of the CHP134 neuroblastoma cell line is associated with nuclear accumulation of p53 and is rescued by the GDNF/Ret signal. (2001) (20)
Effects of hepatic CYP3A4 activity on disposition of micafungin in liver transplant recipients with markedly small-for-size grafts. (2006) (20)
Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. (1992) (20)
Preliminary experience with FK 506 in thoracic transplantation (1991) (20)
Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506. (1990) (20)
Clinical intestinal transplantation. (1996) (20)
E1AF expression is closely correlated with malignant phenotype of tongue squamous cell carcinoma through activation of MT1-MMP gene promoters. (2005) (20)
Identification of epidermal growth factor receptor-derived peptides recognised by both cellular and humoral immune responses in HLA-A24+ non-small cell lung cancer patients. (2004) (20)
The transplantation of gastrointestinal organs. (1993) (20)
Small bowel and liver/small bowel transplantation in children. (1993) (20)
Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. (1996) (20)
Combination treatment with FTY720 and CTLA4IgG preserves the respiratory epithelium and prevents obliterative disease in a murine airway model. (2002) (20)
Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies. (1997) (20)
Clinical intestinal transplantation: focus on complications. (1992) (20)
Intestinal neuromuscular function after preservation and transplantation. (1996) (19)
Upper-abdominal exenteration in transplantation for extensive malignancies of the upper abdomen--an update. (1991) (19)
Long-term acceptance of allografts by in vivo gene transfer of regulatable adenovirus vector containing CTLA4IgG and loxP. (2001) (19)
Liver transplantation in black recipients: Pittsburgh. (1989) (19)
Cold ischemia time vs outcome of human liver transplantation using UW solution. (1991) (19)
Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA. (1990) (19)
Clinical impacts of mesothelin expression in gastrointestinal carcinomas. (2016) (19)
Multivisceral and intestinal transplantation. (1992) (19)
Evolution of surgical techniques in clinical intestinal transplantation. (1994) (19)
Laparoscopic hepatectomy with the hook blade of ultrasonic coagulating shears and bipolar cautery with a saline irrigation system. (2005) (19)
Inhibition of nuclear factor‐kappaB suppresses peritoneal dissemination of gastric cancer by blocking cancer cell adhesion (2011) (19)
Detection of peptide-specific CTL-precursors in peripheral blood lymphocytes of cancer patients (2002) (19)
Donor pretreatment with DHMEQ improves islet transplantation. (2010) (19)
Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2+ cancer patients (2004) (18)
Effect of FK506 in experimental organ transplantation. (1988) (18)
Animal research in liver transplantation with special reference to the dog. (1985) (18)
Multivisceral intestinal transplantation: surgical pathology. (1989) (18)
Infections with FK 506 immunosuppression: preliminary results with primary therapy. (1990) (18)
The use of clonidine for the treatment of high intestinal output following small bowel transplantation. (1997) (18)
CANINE LIVER TRANSPLANTATION UNDER Nva2-CYCLOSPORINE VERSUS CYCLOSPORINE1 (1986) (18)
OKT3 in the reversal of acute hepatic allograft rejection. (1987) (18)
Intestinal transplantation at the University of Pittsburgh: six-year experience. (1997) (18)
Intestinal transplantation at the University of Pittsburgh. (1994) (18)
Early infectious complications of liver-intestinal transplantation in children: preliminary analysis. (1994) (18)
Management and algorithm for focal nodular hyperplasia of the liver in children. (2006) (18)
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent. (1990) (18)
Membranous and cytoplasmic expression of epidermal growth factor receptor in metastatic pancreatic ductal adenocarcinoma. (2012) (18)
Successful transplantation of rat hearts subjected to extended cold preservation with a novel preservation solution (2012) (18)
Meconium pseudocyst with particular pathologic findings: a case report and review of the literature. (2012) (18)
"Munchausen by proxy" syndrome in a small bowel transplant recipient. (1996) (17)
Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression. (1990) (17)
Endorectal pull-through of transplanted colon as part of intestinal transplantation. (1995) (17)
Upper abdominal exenteration with liver replacement: a modification of the "cluster" procedure. (1990) (17)
A novel tumor necrosis factor-alpha suppressant, ONO-SM362, prevents liver failure and promotes liver regeneration after extensive hepatectomy. (2008) (17)
Liver retransplantation in adults: overall results and determinant factors affecting the outcome. (1991) (17)
NF-κB regulates the stability and activity of p73 by inducing its proteolytic degradation through a ubiquitin-dependent proteasome pathway (2006) (17)
She 4 p / Dim 1 p Interacts with the Motor Domain of Unconventional Myosins in the Budding Yeast , Saccharomyces cerevisiae (2003) (17)
Liver Transplantation for the Budd‐Chiari Syndrome (1976) (17)
Beneficial Effects of Costimulatory Blockade with Anti-Inducible Costimulator Antibody in Conjunction with CTLA4Ig on Prevention of Islet Xenograft Rejection from Rat to Mouse (2004) (17)
FK 506 dosage in human organ transplantation. (1990) (17)
Dose-dependent study of a novel immunosuppressant, FTY720, with the canine renal allograft transplantation model. (1999) (17)
Is multiple organ failure a contraindication for liver transplantation in children? (1987) (17)
Rat liver lipids during ex vivo warm and cold ischemia and reperfusion. (1993) (17)
Pediatric liver transplantation from neonatal donors (1992) (17)
Renal function after conversion from cyclosporine to FK 506 in liver transplant patients. (1991) (17)
Expression of ABC transporters in human hepatocyte carcinoma cells with cross-resistance to epirubicin and mitoxantrone. (2006) (17)
Efficacy of DHMEQ, a NF-&kgr;B Inhibitor, in Islet Transplantation: II. Induction DHMEQ Treatment Ameliorates Subsequent Alloimmune Responses and Permits Long-Term Islet Allograft Acceptance (2013) (17)
The use of transesophageal ultrasonography for the diagnosis of inferior vena caval outflow obstruction during liver transplantation. (1992) (17)
First case of cadaveric liver transplantation in Japan. (1999) (16)
Intestinal transplantation in children: five-year experience. (1996) (16)
What is the limit of graft size for successful living donor liver transplantation in adults? (2001) (16)
Multiplication of alpha‐fetoprotein and protein induced by vitamin K absence‐II is a powerful predictor of prognosis and recurrence in hepatocellular carcinoma patients after a hepatectomy (2015) (16)
Indication and strategy for adult living related liver transplantation. (1999) (16)
Endoscopy is essential for early detection of rejection in small bowel transplant recipients. (1994) (16)
Microencapsule technique protects hepatocytes from cryoinjury (2008) (16)
Intestinal transplantation: 4-year experience. (1995) (16)
The effect of FK 506 and CyA on the Lewis rat renal ischemia model. (1990) (16)
The effect of FK-506 on hyperacute rejection in presensitized rats. (1987) (16)
Temporary end-to-side portocaval shunt in orthotopic liver transplantation (1993) (16)
An automated and portable low-flow pulsatile perfusion system for organ preservation (1996) (16)
Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis. (1994) (16)
CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. (1991) (16)
Perforation of the piriform recessus by a swallowed glass splinter presenting as pneumomediastinum in a child (2004) (16)
Long-term outcome of laparoscopic hepatectomy in patients with hepatocellular carcinoma. (2014) (16)
Effect of high concentrations of bile acids on cultured hepatocytes. (1998) (15)
Amelioration of intestinal dysmotility and stasis by octreotide early after small-bowel autotransplantation in dogs. (1995) (15)
Cleavage and polyadenylation specificity factor (CPSF)‐derived peptides can induce HLA‐A2‐restricted and tumor‐specific CTLs in the majority of gastrointestinal cancer patients (2002) (15)
The anterior route for arterial graft conduits in liver transplantation * (1989) (15)
Topical application of dehydroxymethylepoxyquinomicin improves allergic inflammation via NF-kappaB inhibition. (2010) (15)
Chromosomes that show partial loss or gain in near‐diploid tumors coincide with chromosomes that show whole loss or gain in near‐triploid tumors: Evidence suggesting the involvement of the same genes in the tumorigenesis of high‐ and low‐risk neuroblastomas (2003) (15)
Cytomegalovirus disease in intestinal transplantation. (1995) (15)
In‐vitro Interaction of a Novel Immunosuppressant, FK 506, and Antacids (1991) (15)
Protective Effect of TNF-α and IL-1β Inhibitor FR167653 on Ischemia-Reperfusion Injury in Rat Small Intestinal Transplantation (1998) (15)
Lipid peroxidation, brush border, and neutrophil enzyme activity after small bowel preservation: a comparison of preservation solutions. (1992) (14)
Liver transplantation at the University of Pittsburgh, 1984 to 1990. (1991) (14)
Daily serum interleukin-6 monitoring in multiple organ transplantation with or without liver allografts. (1996) (14)
Effective esophageal balloon dilation for esophageal stenosis in recessive dystrophic epidermolysis bullosa. (2006) (14)
p73 and MDM2 confer the resistance of epidermoid carcinoma to cisplatin by blocking p53. (2006) (14)
Clinicopathological significance of nuclear factor‐κB activation in hepatocellular carcinoma (2011) (14)
Disorders of interstitial cells of Cajal in a neonate with segmental dilatation of the intestine. (2010) (14)
The effect of bile duct ligation and bile diversion on FK506 pharmacokinetics in dogs. (1992) (14)
Analogs of cyclic nucleotides in rat liver preservation. (1998) (14)
Functional characterization of naturally occurring mutants (P405R and P425L) of p73α and p73β found in neuroblastoma and lung cancer (2001) (14)
Liver transplantation for primary biliary cirrhosis. (1989) (14)
Human liver xenotransplantation. (1993) (14)
IL-1 and IL-6 induce hepatocyte plasminogen activator inhibitor-1 expression through independent signaling pathways converging on C/EBPdelta. (2007) (14)
The effect of antagonism of adenosine A1 receptor against ischemia and reperfusion injury of the liver. (2007) (14)
Immunological evaluation of vaccination with pre-designated peptides frequently selected as vaccine candidates in an individualized peptide vaccination regimen. (2004) (14)
Intestinal transplantation in 31 adults. (1996) (13)
Attenuation of ischemic liver injury by a non-selective endothelin receptor antagonist. (1997) (13)
Comparative in vitro studies on the immunosuppressive effects of purine and pyrimidine synthesis inhibitors. (1993) (13)
Morphological and functional changes in the tight junctions of the bile canaliculi induced by bile duct ligation (1978) (13)
Tolerance induction by a single donor pretreatment with the adenovirus vector encoding CTLA4Ig gene in rat orthotopic liver transplantation. (2001) (13)
Psychiatric evaluations of small intestine transplantation patients. (1996) (13)
Donor selection and surgical technique for en bloc liver-small bowel graft procurement. (1993) (13)
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. (1993) (13)
Comparison of the small intestine after multivisceral transplantation with the small intestines transplanted with portal or caval drainage. (1992) (13)
Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. (1993) (13)
Lazaroid U-74500A for warm ischemia and reperfusion injury of the canine small intestine. (1997) (13)
Cytokine profile in graft-versus-host disease after small bowel transplantation. (1996) (13)
Effect of 15-deoxyspergualin on experimental organ transplantation. (1988) (13)
Two year experience with FK506 in pediatric patients (1993) (13)
Endoscopic features of acute cellular rejection. (1996) (12)
The effect of FK 506 on small intestine allotransplantation in the rat. (1990) (12)
Variability in the interpretations of endoscopic findings in patients with intestinal transplantation. (1996) (12)
Enhanced Cell Survival and Yield of Rat Small Hepatocytes by Honeycomb-Patterned Films (2008) (12)
Comparison between prenatally diagnosed choledochal cyst and type-1 cystic biliary atresia by CD56-immunostaining using liver biopsy specimens. (2007) (12)
Alveolar echinococcosis of the liver in children (2010) (12)
A new immunosuppressant, FTY720, in canine kidney transplantation: effect of single-drug, induction and combination treatments (2004) (12)
Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats. (1999) (12)
Nutritional management of intestinal allograft recipients. (1998) (12)
Rejection of human intestinal allografts: alone or in combination with the liver. (1994) (12)
Cystic thymoma in a child: a rare case and review of the literature (2007) (12)
Cost-utility of living donor liver transplantation in a single Japanese center. (2006) (12)
Hepatic venous reconstruction of anterior sector using three-dimensional helical computed tomography in living donor liver transplantation. (2006) (12)
Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506. (1991) (12)
Quantitative determination of individual teicoplanin components in human plasma and cerebrospinal fluid by high-performance liquid chromatography with electrochemical detection. (2007) (12)
Thrombopoietin in postoperative thrombocytopenia following living donor hepatectomy (2006) (11)
An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles (2009) (11)
Early infections in kidney transplant recipients under FK 506. (1991) (11)
Effects of FK 506, mycophenolic acid, and bredinin on OKT-3-, PMA-, and alloantigen-induced activation molecule expression on cultured CD4+ and CD8+ human lymphocytes. (1991) (11)
Severe exfoliative rejection after intestinal transplantation in children. (1996) (11)
Fluorometric study of the viability of rat liver grafts after simple cold storage with UW solution versus Euro-Collins solution. (1991) (11)
Induction of graft acceptance after dog kidney or liver transplantation. (1990) (11)
Oral glucose tolerance test in liver recipients treated with FK 506. (1990) (11)
Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator1 (2003) (11)
Multiple mesenteric teratomas: usefulness of spiral computed tomography with 3-dimensional reconstruction. (2006) (11)
Review Article: Small Intestinal Transplantation for Irreversible Intestinal Failure in Children (1997) (11)
Use of the D-xylose absorption test in monitoring intestinal allografts. (1994) (11)
CIRCULATING ICAM‐1, E‐SELECTIN, IL‐2 RECEPTOR, AND HLA CLASS I IN HUMAN SMALL BOWEL, LIVER, AND SMALL BOWEL‐PLUS‐LIVER TRANSPLANT RECIPIENTS (1995) (11)
Deceased donor liver transplantation (2010) (11)
Preservation of livers with UW or Euro-Collins' solution. (1988) (10)
FK 506 in clinical organ transplantation (1991) (10)
Isolation and primary culture of adult human hepatocytes (1981) (10)
Intestinal and multivisceral transplantation. (1995) (10)
Contrast examination of the small bowel in patients with small-bowel transplants: findings in 16 patients. (1993) (10)
Cytokine gene expression in murine lymphocytes activated in the presence of FK 506, bredinin, mycophenolic acid, or brequinar sodium. (1992) (10)
Hepatic artery thrombosis following pediatric liver transplantation: Assessment of blood flow measurement in allografts. (1989) (10)
Technical aspects of intestinal transplantation. (1993) (10)
Focal nodular hyperplasia of the liver: usefulness of superparamagnetic iron oxide-enhanced magnetic resonance imaging. (2005) (10)
Inhibition of thromboxane A2 synthesis by OKY-046 attenuates ischemia and reperfusion injury of the liver. (1999) (10)
Glutamine metabolism of intestine grafts: influence of mucosal injury by prolonged preservation and transplantation. (1996) (10)
Functional characterization of naturally occurring mutants (P405R and P425L) of p73alpha and p73beta found in neuroblastoma and lung cancer. (2001) (10)
Hyperplastic polyp of the gallbladder associated with pancreaticobiliary maljunction in a 9-year-old girl (2009) (10)
Chemosensitivity prediction in esophageal squamous cell carcinoma: novel marker genes and efficacy-prediction formulae using their expression data. (2006) (10)
Comparison of warm and cold ischemia of the canine small intestine. (1995) (10)
THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. (1987) (10)
Transduction of exogenous constitutively activated Stat3 into dispersed islets induces proliferation of rat pancreatic beta-cells. (2006) (10)
The effect of FK 506 on canine pancreatic islet cell function in beagle dogs. (1991) (10)
Levels of purine nucleoside phosphorylase (PNP) as a viability marker of nonparenchymal cells in cold preserved livers. (1991) (10)
Dimeric but not Monomeric Soluble CD40 Prolongs Allograft Survival and Generates Regulatory T Cells that Inhibit CTL Function (2005) (10)
Pediatric Liver Transplantation (1993) (10)
Postoperative portal and splenic vein thrombosis in children: Identification of risk factors (2005) (10)
Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. (1992) (9)
An Analysis of the Causes of Death After Pediatric Liver Transplantation. (1988) (9)
Influence of graft perfusion pressure on graft viability after small bowel preservation and transplantation. (1996) (9)
Assessment of hepatic viability during cold ischemic preservation (1995) (9)
Gene Therapy-Mediated CD40L and CD28 Co-stimulatory Signaling Blockade plus Transient Anti-xenograft Antibody Suppression Induces Long-Term Acceptance of Cardiac Xenografts (2004) (9)
Cold preservation of the human colon and ileum with University of Wisconsin solution (1999) (9)
A short-course therapy with FTY720 prolongs allograft survival after canine kidney transplantation. (1999) (9)
Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia (2006) (9)
Dendritic Cells Conditioned With NK026680 Prolong Cardiac Allograft Survival in Mice (2012) (9)
Immunosuppressive Effects of DTCM-G, a Novel Inhibitor of the mTOR Downstream Signaling Pathway (2013) (9)
DFF45/ICAD restores cisplatin-induced nuclear fragmentation but not DNA cleavage in DFF45-deficient neuroblastoma cells (2007) (9)
Surgical stress and tumor behavior: Impact of ischemia‐reperfusion and hepatic resection on tumor progression (2007) (9)
Initial studies with FK506 in renal transplantation. (1991) (9)
Influence of continuous venovenous haemodiafiltration on the pharmacokinetics of tacrolimus in liver transplant recipients with small‐for‐size grafts (2003) (9)
Comparison of short-term immunosuppressive therapy with cyclosporine and FK 506 in small-bowel transplantation. (1990) (9)
Infections in pediatric liver recipients treated for acute rejection. (1989) (9)
Histologic spectrum of acute cellular rejection in human intestinal allografts. (1996) (9)
Bleeding disorder as the first symptom of biliary atresia. (2005) (9)
Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms (2015) (9)
Biochemical evidence of mucosal damage of intestinal grafts during cold preservation in University of Wisconsin, Euro-Collins, and lactated Ringer's solutions. (1994) (9)
Tacrolimus in solid organ transplantation (1996) (8)
Therapeutic synergism between low-dose FK 506 and antimetabolites in rat allogeneic heart transplantation. (1995) (8)
Venovenous bypass using inferior mesenteric vein for portal decompression during orthotopic hepatic transplantation. (1995) (8)
NFBD1/MDC1 stabilizes oncogenic MDM2 to contribute to cell fate determination in response to DNA damage. (2008) (8)
Correlation between elevated intratumoral thymidine phosphorylase and prognosis of node-positive breast carcinoma undergoing adjuvant doxifluridine treatment. (2000) (8)
Can adenine nucleotides predict primary nonfunction of the human liver homograft? (1994) (8)
Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. (1991) (8)
Pancreatic complications following orthotopic liver transplantation. (1992) (8)
Effect of endogenous adenosine augmentation on ischemia and reperfusion injury to the liver. (1997) (8)
The variability of liver graft function and urinary 6β‐hydroxycortisol to cortisol ratio during liver regeneration in liver transplant recipients (2004) (8)
Modified simple cold storage of rat livers with UW solution. (1994) (8)
A CASE OF LUNG METASTASIS OCCURRING 6 YEARS AFTER PANCREATICODUODENECTOMY FOR PANCREAS CANCER (2010) (8)
Intestinal transplantation with or without other abdominal organs: nutritional and dietary management of 50 patients. (1994) (8)
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. (1987) (8)
The anterior route for arterial graft conduits in liver transplantation (1989) (8)
The Impact of c‐Fos/Activator Protein‐1 Inhibition on Allogeneic Pancreatic Islet Transplantation (2015) (8)
Development of a yeast stop codon assay readily and generally applicable to human genes. (2001) (8)
Immunomodulatory Effect of Nuclear Factor-&kgr;B Inhibition by Dehydroxymethylepoxyquinomicin in Combination With Donor-Specific Blood Transfusion (2012) (8)
A Randomized Controlled Study of Immunochemotherapy with OK-432 after Curative Surgery for Gastric Cancer (2004) (8)
Morphological monitoring of human small bowel allografts. (1993) (8)
Liver and small bowel transplantation for short gut syndrome in a child (1991) (8)
FK 506 prevents spontaneous diabetes in the BB rat. (1991) (8)
Liver allograft pathology in liver/small bowel or multivisceral recipients. (1996) (8)
Immunohistochemical study of enteric nervous system after small bowel transplantation in humans (1994) (8)
The Denver-Pittsburgh liver transplant series. (1987) (8)
Long-term nutritional monitoring after clinical intestinal transplantation. (1998) (7)
Hospitalization and readmission of intestinal transplantation recipients. (1994) (7)
A nomogram for predicting the optimal oral dosage of tacrolimus in liver transplant recipients with small‐for‐size grafts (2006) (7)
Successful liver transplantation for isoniazid-induced hepatic failure--a case report. (1994) (7)
Factors associated with recurrent cytomegalovirus disease after small bowel transplantation. (1994) (7)
Living-donor liver transplantation for hepatocellular carcinoma. (2006) (7)
Sotrastaurin, a new selective protein kinase C inhibitor, on the way. (2012) (7)
Differential levels of human leukocyte antigen-class I, multidrug-resistance 1 and androgen receptor expressions in untreated prostate cancer cells: the robustness of prostate cancer. (2007) (7)
Anoikis induction and inhibition of peritoneal metastasis of pancreatic cancer cells by a nuclear factor-κB inhibitor, (-)-DHMEQ. (2013) (7)
Liquid chromatographic method for the determination of sirolimus in blood using electrochemical detection. (2009) (7)
Prospective evaluation of endoscopy in acute cellular rejection and cytomegalovirus infection. (1996) (7)
Liver transplantation in older patients (Letter) (1987) (7)
Clinical and endoscopic features of rejection in small bowel transplant recipients. (1994) (7)
Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet. (1998) (7)
Histological differentiation between prenatally diagnosed choledochal cyst and type I cystic biliary atresia using liver biopsy specimens. (2006) (7)
[Liver regeneration in living-donor liver transplantation]. (2004) (7)
Effectiveness of using ultrasonically activated scalpel in combination with radiofrequency dissecting sealer or irrigation bipolar for hepatic resection. (2012) (7)
Abnormal gastric emptying after intestinal transplantation. (1994) (7)
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. (1988) (7)
Influence of donor criteria on early outcome after intestinal transplantation. (1997) (7)
Adenovirus-mediated CTLA4-IgG gene therapy in orthotopic small intestinal transplantation in rats. (2001) (7)
Increased cyclosporine uptake by cells pretreated with FK506 and evidence for binding of both drugs to a common intracellular protein. (1989) (7)
Effect of anticomplement agent K-76 COOH in hamster-to-rat and guinea pig-to-rat xenotransplantation. (1995) (6)
Analysis of risk factors for hyperbilirubinemia occurring after hepatectomy (2011) (6)
Comparison of the small intestines after multivisceral transplantation and the small intestine transplanted with portal versus caval drainage (1992) (6)
Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents. (1997) (6)
Intestinal neurons in acute and chronic rejection after small bowel transplantation in dogs. (1996) (6)
Histologic monitoring of human small bowel allografts with clinical correlation. (1992) (6)
Gastrointestinal motility in the immediate postoperative period after intestinal transplantation, with special reference to acute rejection. (1994) (6)
Amelioration of liver damage induced by ischemia and reperfusion with FR167653; a newly synthesized cytokine suppressive antiinflammatory drug. (1998) (6)
Candidates for intestinal transplantation and possible indicators of outcome. (1994) (6)
Laparoscopic liver biopsy using cup-shaped punch biopsy forceps and argon beam coagulator in children (2007) (6)
Disturbance of microcirculation associated with prolonged preservation of dog livers under University of Wisconsin solution. (1993) (6)
Combined liver and kidney transplantation with particular reference to positive cytotoxic crossmatches (1989) (6)
The current status of hepatic transplantation at the University of Pittsburgh. (1995) (6)
A technique for orthotopic liver transplantation in cynomolgus monkeys. (2014) (6)
Intestinal and multiple organ transplantation (1995) (6)
Intestinal retransplantation. (1996) (6)
Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report. (1991) (6)
Eating difficulties in the pediatric small bowel recipient: the role of the nutritional management team. (1994) (6)
Identification of squamous cell carcinoma antigen-derived peptides having the capacity of inducing cancer-reactive CTLs in HLA-A24+ cancer patients. (2006) (6)
Bone marrow augmentation for heart, liver, and small bowel transplantation: prolongation of graft survival and incidence of graft-versus-host disease. (1995) (6)
Protective effect of TNF-alpha and IL-1 beta inhibitor FR167653 on ischemia-reperfusion injury in rat small intestinal transplantation. (1998) (5)
Hepatic transplantation at the University of Pittsburgh: new horizons and paradigms after 30 years of experience. (1994) (5)
Effect of glucose introduction to the lumen during cold ischemia in rat small bowel. (1996) (5)
Daily serum inflammatory cytokine (tumor necrosis factor-alpha, interleukin-6) monitoring in liver transplantation focusing on allograft rejection: a five-case report. (1996) (5)
Hepatis B virus (HBV) re-infection following liver transplantation: Theory and practice (1995) (5)
Long-term effect of jejunoileal autotransplantation on motility and transit time in canine small bowel. (1994) (5)
Histopathologic changes of antibody-mediated small bowel graft rejection in blood-transfused recipients. (1996) (5)
Effect of FK 506 in the prophylaxis of autoimmune glomerulonephritis in NZB/WF1 mice. (1991) (5)
Improved survival with cytomegalovirus infection after intestinal transplantation in children. (1996) (5)
Monoclonal antibody therapy with ciclosporin and steroids in nonmatched cadaveric renal transplants. (1987) (5)
Novel Cell Culture Substrates based on Micro-Porous Films of Amphiphilic Polymers (2001) (5)
Induction of insulin-dependent diabetes mellitus by total pancreatectomy for pancreatic islet transplantation in cynomolgus monkeys (2012) (5)
Ischemia and reperfusion injury of the human colon and ileum. (1996) (5)
Comparison of various lazaroid compounds for protection against ischemic liver injury. (1997) (5)
Combined liver-islet allotransplantation in man under FK 506. (1991) (5)
Effect of rejection on electrophysiologic function of canine intestinal grafts: correlation with histopathology and Na-K-ATPase activity. (1995) (5)
Comparative pharmacokinetics of cyclosporine and NVa2-cyclosporine in dogs. (1987) (5)
A simple and reliable method for determining plasma concentration of dehydroxymethylepoxyquinomicin by high performance liquid chromatography with mass spectrometry. (2008) (5)
Venous-right atrial bypass for superior vena cava thrombosis during orthotopic liver transplantation. (1997) (5)
α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma. (2012) (5)
Gastrointestinal posttransplant lymphoproliferative disease in children after small intestinal transplantation. (1996) (5)
Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. (1996) (5)
Effects of preformed antibodies induced by whole blood transfusion on small bowel transplantation. (1994) (5)
Usefulness of axial planes of helical computed tomography for diagnosis of pancreaticobiliary maljunction in early infants with negative findings on magnetic resonance cholangiopancreatography. (2008) (5)
Nonfamilial Juvenile Polyposis Coli in a Child: Report of a Case (2004) (5)
Interaction between FK 506 and cyclosporine in dogs. (1991) (5)
IMMUNOSUPPRESSION WITH FR 900506 FOR CANINE KIDNEY AND LIVER TRANSPLANTATION. (1987) (4)
Cadaveric domino liver transplantation: the first case in Japan. (2004) (4)
Noble gene transduction into pancreatic beta-cells by singularizing islet cells with low doses of recombinant adenoviral vector. (2008) (4)
Role of local renin-angiotensin system in warm ischemia and reperfusion injury of the liver. (2001) (4)
Management of massive hemobilia with angiographic embolization (1983) (4)
Beta-glucan reflects liver injury after preservation and transplantation in dogs. (1999) (4)
Chondroma of the diaphragm mimicking a giant liver tumor with calcification: report of a case (2014) (4)
Cyclosporine G Analysis and Monitoring by High-Pressure Liquid Chromatography. (1986) (4)
Advances in Brief Identification of a Transactivation Activity in the COOH-Terminal Region of p 73 Which Is Impaired in the Naturally Occurring Mutants Found in Human Neuroblastomas 1 (1999) (4)
CD56-immunostaining of the extrahepatic biliary tree as an indicator of clinical outcome in biliary atresia: a preliminary report. (2008) (4)
Novel CD40-IgG adenovirus-mediated gene therapy as a potent immunosuppressive treatment for liver transplantation in rats. (2001) (4)
Early clinical and histologic viability of human liver-small intestinal allografts after implantation. (1994) (4)
Multivisceral allotransplantation in pigs. (1996) (4)
Liver transplantation today. (1987) (4)
HEPATOTROPHIC EFFECTS OF FK 506 IN DOGS ! (2010) (4)
Evaluation of solutions for canine small bowel preservation. (1996) (4)
TWO CASES OF INTRA-ABDOMINAL DESMOID TUMOR (2008) (4)
Water, sodium, potassium, and D-xylose absorption in canine small bowel transplantation. (1994) (4)
Prolonged small bowel graft survival using photochemotherapy and low-dose FK 506. (1996) (4)
Attenuation of hepatic ischemia and reperfusion injury by serine protease inhibitor, FUT-175, in dogs. (2001) (4)
Effect of CMV serology on outcome after clinical intestinal transplantation. (1996) (4)
Electron microscopic observations on the cholesterol distributed in the epithelial cells of the gallbladder (1975) (4)
Tacrolimus (FK 506)-dependent tolerance after liver and heart xenotransplantation: inhibition of humoral response and acceptance of donor organs. (1996) (4)
The role of endothelin-1 in hepatic ischemia and reperfusion injury (2002) (4)
Vascular versus luminal flushing for preservation of canine small bowel. (1994) (4)
Hepatocellular Carcinoma Extending into Right Atrium was Resected Successfully Using Cardiopulmonary Bypass (2006) (4)
Pediatric alveolar echinococcosis invading the diaphragm and spreading to the chest and abdominal wall. (2010) (4)
Graft-versus-host disease in fully allogeneic small bowel transplantation: incidence of the disease and strain combinations. (1993) (3)
Susceptibility to ischemia: the large bowel versus the small bowel. (1994) (3)
EFFECTS OF A NOVEL IMMUNOSUPPRESSANT, FTY720, ON HEART AND LIVER TRANSPLANTATIONS IN RATS. (1999) (3)
Treatment with FK 506 of steroid resistent focal sclerosing glomerulonephritis (FSGN) of childhood (Letter) (1990) (3)
Evidence of dual function of macrophage migration inhibitory factor relevant to tumor progression and regression. (2005) (3)
EFFECT OF FK-506 ON GASTROINTESTINAL-TRACT - COMPARISON WITH ERYTHROMYCIN (1993) (3)
A Case of Adenocarcinoma of the Sigmoid Colon with Pelvic Arteriovenous Malformation (2010) (3)
Inhibition of type II phospholipase A(2) by LY329722 attenuates ischemia and reperfusion injury of canine livers. (2001) (3)
Successful 48-hour preservation of the canine liver by modified simple hypothermic storage with University of Wisconsin solution. (1995) (3)
Basic considerations for the procurement of intestinal grafts. (1994) (3)
Three-dimensional volumetric analysis for reconstruction of middle hepatic vein tributaries in living donor liver transplantation. (2005) (3)
Influence of donor-recipient strain combinations on immunologic responses after allogeneic rat small bowel transplantation. (1994) (3)
Is rejection a diffuse or localized process in small-bowel transplantation? (1994) (3)
Notes on FK 506. (1991) (3)
Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts. (1994) (3)
Chylous ascites caused by resection of a choledochal cyst. (2012) (3)
Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease (2016) (3)
Antibody-Mediated Rejection of Human Orthotopic Liver Allografts A Study of Liver Transplantation Across ABO Blood (1988) (3)
Transplantation of the small bowel and other abdominal organs in humans (1994) (3)
A modified technique of orthotopic transplant of the kidney in rabbits. (1989) (3)
Effect of a new immunosuppressive agent, KF20444, in rat cardiac transplantation. (1999) (3)
Sodium lactobionate sucrose solution for canine liver and kidney preservation. (1993) (3)
Screening of new bioactive metabolites for diabetes therapy (2013) (3)
Role of the liver and the portal circulation in intestinal grafting (1993) (3)
THE PROTECTIVE EFFECT OF FK 506 PRETREATMENT AGAINST RENAL ISCHEMIAjREPERFUSION INJURY IN RATS (2010) (3)
Liver transplantation for hepatitis B: what have we learned and what does the future hold? (1995) (3)
Liver Resection forHilar and Peripheral Cholangiocarcinomas (1998) (3)
Inducion of Operational Tolerance By a Cell Therapy Using Donor Ag-Pulsed Tregs in Living Donor Liver Transplantation.: Abstract# 2865 (2014) (3)
Hepatopulmonary Fistula Caused by Alveolar Echinococcosis: Report of a Case (2006) (3)
Morphology of acute rejection and observation of lymphoproliferative hyperplastic reaction in FK 506 treated pigs after small bowel transplantation. (1994) (2)
The Importance of Bringing Transplantation Tolerance to the Clinic. (2021) (2)
Monitoring of intestinal myoelectrical activity after isolated small bowel transplantation in FK 506 immunosuppressed pigs. (1994) (2)
Specific effect of University of Wisconsin solution on renal hemodynamics and microvasculature in canine kidney preservation. (1990) (2)
p66Shc Plays a Pivotal Role in Impaired Liver Regeneration in Aged Mice by a Redox-dependent Mechanism (2010) (2)
[In vitro chemosensitivity test for hepatocellular carcinoma using collagen-gel droplet embedded cultures]. (2004) (2)
Perioperative treatment with phosphatidic acid inhibitor (Lisofylline leads to prolonged survival of hearts in the guinea pig to rat xenotransplant model. (1996) (2)
A CASE REPORT OF RESECTED HEPATOCELLULAR CARCINOMA WITH SARCOMATOUS CHANGE (2007) (2)
A Selective NF-?B Inhibitor, DHMEQ, Inhibits Allergic Inflammation And Airway Remodeling In A Murine Model Of Asthma (2011) (2)
A Case of Focal Nodular Hyperplasia Difficult to Diagnose Preoperatively (2008) (2)
Mechanisms of hamster kidney graft rejection in the rat. (1994) (2)
Interferon-b Inhibits Liver Metastases from Murine Colon 26 Carcinoma and its Highly Metastatic Variant (2007) (2)
NK026680 inhibits T-cell function in an IL-2-dependent manner and prolongs cardiac allograft survival in rats. (2012) (2)
Rat small hepatocytes for liver support: growth and metabolic activities in culture (2002) (2)
Functional analysis of hamster kidney xenografts in the rat: possible functional incompatibility and adaptation of hamster kidney grafts in a xenogenic rat environment. (1996) (2)
Tube choledochoureterostomy: a simple method for bile diversion. (1990) (2)
A CASE OF RESECTED HEPATOCELLULAR CARCINOMA WITH PRIMARY BILLARY CIRRHOSIS (2009) (2)
Circulating adhesion molecules and other soluble markers of immune activation in human small bowel and small bowel plus liver transplantation. (1994) (2)
[Weekly paclitaxel administration in the adjuvant therapy of primary breast cancer]. (2003) (2)
A Case of Extramedullary Plasmacytoma of the Ileum (2005) (2)
Persistence of donor cells and incidence of graft-versus-host disease after simultaneous small bowel and bone marrow transplantation. (1996) (2)
Hamster to rat kidney xenotransplantation: effects of FK506, cyclophosphamide, and organ perfusion (1995) (2)
Nitric oxide enhancement attenuates ischemia and reperfusion injury of canine livers. (1999) (2)
[Impact of desensitization for ABO-blood barrier on living donor liver transplantation for hepatocellular carcinoma]. (2014) (2)
MORE THAN SIX YEARS ACTUAL FOLLOW-UP:CONVERSION FROM CYCLOSPORINE TO TACROLIMUS FOR CHRONIC LIVER ALLOGRAFT REJECTION (1999) (2)
An isolated complete intestinal transplantation in an adult: A complicated postoperative course (1992) (2)
Living liver donation for adult living-related liver transplantation. (2000) (2)
Amelioration of Hyperglycemia in Streptozotocin-Induced Diabetic Mice With Fetal Pancreatic Allografts: Prevention of Rejection by Donor Specific Transfusion in Conjunction With CTLA4Ig (2004) (2)
A CASE OF PRIMARY HEPATIC CARCINOID TUMOR (2009) (2)
Elevation of cyclic nucleotides attenuates ischemia and reperfusion injury of liver. (2001) (2)
[Current status of pediatric intestinal transplantation]. (2010) (2)
Menkes disease with gastroesophageal reflux disease and successful surgical treatment: a case report and literature review. (2010) (2)
Role of xanthine-oxidase system in mucosal injury after intestinal preservation and transplantation. (1993) (2)
Intestinal transplantation in children after primary liver transplantation. (1998) (2)
Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine. (1993) (2)
Immunoreactivity of T lymphocytes propagated from biopsies of human cadaveric small intestine allografts: a serial study of four patients. (1992) (2)
Preformed antibodies in sensitized recipients: effect of immunoglobulin titer, class, and specificity on liver and heart allografts. (1993) (2)
Effect of Chronic Therapy on Absorption and Disposition of Cyclosporine. (1988) (2)
Abstract of Poster Presentation (2005) (2)
Abstract 686: IL-1 and IL-6 Induce Hepatocyte Plasminogen Activator Inhibitor-1 Expression Through Independent Signaling Pathways Converging on C/EBP{delta} (2006) (2)
II: THE INDUCTION OF GRAFT ACCEPTANCE IN RATSl (1990) (2)
Prevention of spontaneous diabetes in the BB rat with FK 506 (Letter) (1990) (2)
GRAFT-VERSUS-HOST DISEASE AFTER BROWN NORWAY-TO-LEWIS AND LEWIS-TO-BROWN NORWAY RAT INTESTINAL TRANSPLANTATION UNDER FK 506 (2010) (2)
Effect of preoperative thoracic duct drainage on canine kidney transplantation. (1996) (2)
A new immunosuppressant, FTY720, in canine kidney transplantation: effect of single‐drug, induction and combination treatments (2004) (2)
Expressive dysplasia possibly related to FK 506 in 2 liver transplantation recipients (1990) (2)
The effect of preservation fluid on the blood flow of pediatric liver allografts. (1989) (2)
Rejection of human intestinal allografts (1994) (1)
Biochemical monitors of rejection in canine small bowel transplantation. (1994) (1)
[Small bowel transplantation]. (2005) (1)
A CASE OF RESECTABLE SIMPLE LIVER METASTASES FROM BREAST CANCER AFTER A 10-YEAR DISEASE FREE INTERVAL (1999) (1)
World's longest surviving liver‐pancreas recipient (2007) (1)
A CASE OF SQUAMOUS CELL CARCINOMA OF THE GALLBLADDER RESECTED BY HEPATOPANCREATICODUODENECTOMY (2004) (1)
[Comparison of crossing-over between 30-minute drip infusion vs 30-second injection of granisetron for nausea and vomitting with cisplatin]. (1998) (1)
Present status of the cluster transplantation and its variants (1991) (1)
A Case of Clear Cell Adenocarcinoma Arising in the Endometriosis of the Rectum (2009) (1)
A case of amebic liver abscess. (1985) (1)
Orthotopic liver transplantation for alpha_x001E_1_x001E_antitrypsin deficiency: An experience in 29 children and ten adults (1987) (1)
Serum cytokine levels after small bowel transplantation in pigs. (1994) (1)
The prophylaxis for HCV recurrence in living donor liver transplantation: a preliminary report (2005) (1)
A CASE OF PAGET'S DISEASE OF THE BREAST IN AN 83-YEAR-OLD MALE (2001) (1)
Inhibitory effects of FK506 in combination with CsA on human lymphocyte alloproliferative responses (1989) (1)
The antibody cross match in liver transplantation (2010) (1)
Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors (2017) (1)
A Case of Adenocarcinoma with Pagetoid Spread at the Colostomy Site (2012) (1)
USEFULNESS OF STEREOTACTIC VACUUM-ASSISTED NEEDLE (MAMMOTOME) BIOPSY (2004) (1)
Switching from organ preservation to repair:Significance of mitochondrial function and intracellular Ca 2 ＋ kinetics (2012) (1)
[Clinical intestinal transplantation at the University of Pittsburgh: an update]. (1996) (1)
A Selective NF-kB Inhibitor, DHMEQ, Inhibits Allergic Inflammation in a Murine Model of Asthma. (2009) (1)
Human intestinal and multivisceral transplantation (1994) (1)
Surgical Rsection after Chemoradiation Therapy in a Patient with Locally Advanced Pancreas Carcinoma: A Case Report (2007) (1)
Progress in liver transplantation. (1988) (1)
Maintenance of morphology and function of mixed liver cell spheroids under collagen gel environment (2001) (1)
Resection of liver metastasis derived from alpha-fetoprotein-producing gastric cancer—report of 4 cases (2016) (1)
Ten-year results of a randomized trial on adjuvant chemo-endocrine therapy with tamoxifen for stage II breast cancer (2003) (1)
184 Intestinal and Multiple Organ Transplantation (1)
EFFECT OF ASKP1240 (4D11), A FULLY HUMAN ANTI-CD40 MONOCLONAL ANTIBODY, ON A SINGLE DONOR-DERIVED ALLOGENEIC ISLET TRANSPLANTATION IN CYNOMOLGUS MONKEYS: 794 (2010) (1)
A CASE OF QUADRUPLE CANCER INCLUDING MULTIPLE REMNANT GASTRIC CANCER (2004) (1)
Efficacy and Long-term impact of Preoperative Portal Vein Embolization with Dehydrated Ethanol in Patients with Primary Liver Cancer. (2001) (1)
Two Cases of Hepatic Alveolar Echinococcosis with Complete Obstruction of the Inferior Vena Cava (2004) (1)
Effect of dipyridamole on ischemia and reperfusion injury of canine liver. (2001) (1)
Clinical xenotransplantation (1994) (1)
Endoscopic naso-pancreatic drainage for the treatment of pancreatic fistula occurring after LDLT. (2011) (1)
EFFECT OF INHIBITION OF TISSUE FACTOR ON NONHUMAN PRIMATE ISLET ALLOGRAFT SURVIVAL (2006) (1)
A CLINICAL STUDY OF COLORECTAL CANCER WITH OTHER PRIMARY CARCINOMA (2003) (1)
Clinical implications of luminal membrane expression of mesothelin in intraductal papillary mucinous neoplasms. (2013) (1)
Lazaroid U74006F for canine small bowel preservation. (1996) (1)
[A study of cirrhotic patients with hepatocellular carcinoma and huge splenomegaly who received treatment for hepatocellular carcinoma with concomitant splenectomy]. (2010) (1)
An overview on clinical organ transplantation under FK 506 (1991) (1)
A CASE OF RESECTED LIVER METASTASIS FROM AN EARLY ADENOSQUAMOUS CARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION (2005) (1)
A β-tubulin 5-derived peptide induces cytotoxic T lymphocytes restricted to the HLA-A24 allele in prostate cancer patients. (2010) (1)
Studies of the hepatotrophic qualities of FK 506 and cyclosporine (1990) (1)
Anti-Donor Regulatory T-Cell Therapy in Adult-to-Adult Living Donor Liver Transplantation: A Case Report. (2021) (1)
A CASE OF OMENTAL CYST IN ADULT (2006) (1)
The effect of FK 506 and cyclosporine A on the Lewis rat renal ischemia model (1990) (1)
3-[(Dodecylthiocarbonyl)Methyl]-Glutarimide Attenuates Graft Arterial Disease by Suppressing Alloimmune Responses and Vascular Smooth Muscle Cell Proliferation (2015) (1)
[A phase I study of postoperative combination therapy with TS-1 and low dose cisplatin against stage IV gastric carcinoma]. (2007) (1)
A CASE OF LYMPH NODE METASTASIS FROM SMALL HEPATOCELLULAR CARCIHNOMA (2005) (1)
Functional characteristics of lymphocytes propagated from a human multivisceral allograft. (1990) (1)
Microbial flora alterations in jejunum and colon after chemical bowel preparation before Kasai hepatoportojejunostomy. (2007) (1)
LIVER AND INTESTINE TRANSPLANTATION (1996) (1)
Use of FK 506 in the treatment of liver allograft rejection (1991) (1)
Severe tissue damage occurs during cold preservation of liver grafts. (1993) (1)
Extrinsic reinnervation of the intestine after small bowel autotransplantation in dogs. (1994) (1)
A CASE OF HEPATIC METASTASES FROM A SUBMANDIBULAR GLAND CANCER DIAGNOSED 25 YEARS AFTER RESECTION OF THE PRIMARY TUMOR (2010) (1)
Phase II Study of Docetaxel and S-1Combination Therapy for Advanced or Recurrent Gastric Cancer (2006) (1)
A NOVEL IMMUNOSUPPRESSIVE AGENT, DTCM-GLUTARIMIDE MARKEDLY PROLONGS CARDIAC ALLOGRAFT SURVIVAL IN MOUSE WHEN COMBINED WITH DONOR SPECIFIC TRANSFUSION: 478 (2010) (1)
Comparative study of pharmacokinetic profile following intravenous infusion of tacrolimus in pediatric and adult liver transplant recipients (1995) (1)
Liver transplantation for primary and secondary hepatic malignancies: radiologic considerations (1991) (1)
Prolongation of pig_x001E_to_x001E_dog renal xenograft survival by modification of the inflammatory mediator response (1987) (1)
Liver transplantation In patients with situs (2010) (1)
Idiopathic thrombocytopenic purpura complicated with biliary atresia: a rare occurrence and literature review. (2009) (1)
[Neoadjuvant chemoradiotherapy for advanced squamous cell carcinoma of thoracic esophagus]. (2004) (1)
The Case of resected Hepatic Epithelioidhemangio Endothelioma associated with Focal Nodular Hyperplasia and Hepatic Cavernous Hemangioma (2011) (1)
[Modified pharmacokinetic modulation chemotherapy (PMC) with medication of UFT and intraarterial infusion of 5-FU for advanced unresectable HCC]. (2002) (1)
Post-operative care of small bowel transplant recipients (1993) (1)
Hepatitis B virus (HBV) re-infection following liver transplantation: theory and practice. (1995) (1)
HAMSTER TO RAT KIDNEY XENOTRANSPLANTATION (2010) (1)
HEPATIC INFLOW INFLUENCE UPON PORTAL VEIN COMPLICATIONS IN PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION: 1294 (2008) (0)
Role of Percutaneous Transhepatic Biliary Endoprostheses with Distal Tube Implantation in the Subcutaneous Space for Management of Patients with Postoperative Biliary Stricture (2012) (0)
Clinical experience with liver preservation (1991) (0)
[Liver transplantation from brain dead patients]. (2001) (0)
LIVING DONOR LIVER TRANSPLANTATION FOR FULMINANT HEPATIC FAILURE: AN IMPLICATION OF PREOPERATIVE APHERESIS THERAPY: 3020 (2010) (0)
INDUCTION OF IMMUNOSUPPRESSIVE DENDRITIC CELLS BY A NOVEL NUCLEAR FACTOR-KAPPA B INHIBITOR, DHMEQ: 817 (2008) (0)
IS-3-8 Living donor liver transplantation for hepatocellular carcinoma : Japanese experience(Liver transplantation in the treatment of hepatocellular carcinoma:Current status and future perspectives in the Japanese society,International Symposium(3)) (2010) (0)
RFA for Small Breast Cancer — What Tumor Can Be Treated Safely? (2009) (0)
Donor procurement for intestinal transplantation (1997) (0)
ANALYSIS OF HEPATIC STEATOSIS AFTER PEDIATRIC LIVING DONOR LIVER TRANSPLANTATION: 1287 (2008) (0)
Quantitative Assessment of Hepatic Tissue Perfusion by Contrast Ultrasonography (2005) (0)
APRV in patients with atelectasis after liver transplantation. (2014) (0)
A CASE OF RUPTURED HEPATOBLASTOMA PERFORMED CURATIVE RESECTION AFTER CONCERVATIVE TREATMENT FOLLOWED BY GENERAL CHEMOTHERAPY (2011) (0)
Potential role of FDG-PET to evaluate the outcome of post neoadjuvant chemoradiation for locally advanced pancreatic cancer (2011) (0)
[Effects of pharmacokinetic modulation chemotherapy (PMC) using oral UFT and venous 5-FU infusion as adjuvant chemotherapy for intrahepatic cholangiocellular carcinoma]. (2009) (0)
Flow cytometric analysis of activation actigens on human T-cell subsets: Influence of the immunosuppressive macrolide FK-506 and nucleotide synthetase inhibitors (1991) (0)
PROTECTIVE EFFECT OF ANGIOTENSIN II TYPE 1 RECEPTOR ANTAGONIST ON ISCHEMIA AND REPERFUSION INJURY OF THE LIVER.: Abstract# 64 (2000) (0)
A SUCCESSFUL PANCREATIC ISLET ISOLATION IN CYNOMOLGUS MONKEYS: 779 (2010) (0)
[Postoperative adjuvant intraarterial chemotherapy of combined cisplatin and 5-FU for advanced hepatocellular carcinoma]. (2003) (0)
Identification of de novo STAT3 target gene in liver regeneration (2008) (0)
A STUDY OF POSTOPERATIVE FOLLOW-UP OF PATIENTS WITH BREAST CANCER IN TERMS OF THE OPPORTUNITY OF DETECTING THE RECURRENCE (2006) (0)
[Indication, management and problems of alcoholic liver diseases for liver transplantation: current status in Japan, US and Europe]. (2007) (0)
TWO CASES OF LITTRE'S HERNIA IN A NEWBORN AND AN INFANT (1998) (0)
Abstract 3612: Myocardial Protection With a Novel Organ Preservation Solution Containing Deuterium Oxide for Prolonged Cold Ischemia of the Heart (2009) (0)
[A successful case of systemic chemotherapy followed by liver resection for advanced hepatocellular carcinoma with highly vascular invasion and multiple pulmonary metastases]. (2011) (0)
PREOPERATIVE RISK FACTORS OF ADULT-TO-ADULT LIVING DONOR LIVER TRANSPLANTATION: 2971 (2010) (0)
Hemodynamic changes during acute rejection of small bowel allografts. (1994) (0)
Functional analysis of graft lamina propria associated lymphocytes from a recipient of a human cadaveric small bowel allograft primarily immunosuppressed with FK 506. (1991) (0)
Comparison of in vitro electrophysiological function with histology and mucosal Na-K-ATPase activity in canine small bowel transplantation. (1994) (0)
Replacement of donor lymphoid tissue after small bowel tramsplantation (1991) (0)
A NOVEL HYDROXYL RADICAL SCAVENGER, NICARAVEN, ATTENUATES ISCHEMIA REPERFUSION INJURY OF THE LIVER (1998) (0)
Rapidly enlarging solitary nonparasitic cyst of the liver in a child presenting as acute abdomen (2007) (0)
[Prognosis and preoperative imaging of patients with small hepatocellular carcinoma]. (1997) (0)
[Clinical experience with FK 506]. (1991) (0)
Early clinical experience with cluster resection and transplantation for right upper quadrant abdominal malignancy (1991) (0)
[ACTH unresponsiveness, a case of 13 years old boy (author's transl)]. (1979) (0)
LIVING-RELATED AUXILLARY PARTIAL ORTHOTOPIC LIVER TRANSPLANTATION FOR FLUMINANT HEPATIC FAILURE (1999) (0)
A CASE OF HISTIOCYTOID BREAST CARCINOMA PRESENTED WITH BILATERAL SECONDARY BREAST CANCER (2001) (0)
PROTECTIVE EFFECT OF ANGIOTENSIN II TYPE I RECEPTOR ANTAGONIST, CV-11974, ON ISCHEMIA AND REPERFUSION INJURY OF THE LIVER1 (2001) (0)
Morphology and functions of mature hepatocytes and small hepatocytes on Honeycomb-patterned film (2006) (0)
Renal transplantation in baboons under FK 506. (1989) (0)
Clinical experience with FK 506 (Editorial) (1991) (0)
DIAGNOSIS AND TREATMENT OF INSULIN PRODUCING TUMOR OF THE PANCREAS (1980) (0)
Chylous ascites after nephrectomy without lymphadenectomy for malignant rhabdoid tumor of the kidney: A rare occurrence and literature review (2009) (0)
Triazolopyrimidine derivative NK026680 and donor-specific transfusion induces CD4+CD25+Foxp3+ T cells and ameliorates allograft rejection in an antigen-specific manner. (2020) (0)
LACTATING ADENOMA PRESENTING AS A RAPIDLY ENLARGING BREAST MASS -A CASE REPORT- (2006) (0)
THREE CASE REPORTS OF PRIMARY HYPERPARATHYROIDISM OCCURRING DURING PREGNANCY (2009) (0)
A STUDY OF BREAST CARCINOMA WITH FINDING OF FINE CALCIFICATION DETECTED BY SCREENING MAMMOGRAPHY WITHOUT ANY FINDINGS ON PALPATION AND ULTRASONOGRAPHY (2003) (0)
A SINGLE INFUSION OF THE EX-VIVO GENERATED IMMUNO-REGULATORY DENDRITIC CELLS UNDER A NOVEL AGENT, NK026680 MARKEDLY PROLONGS CARDIAC ALLOGRAFT SURVIVAL: 643 (2010) (0)
EFFECT OF NF-FÉB INHIBITON BY DHMEQ ON ISLET TRANPLANTATION IN MICE: 763 (2008) (0)
The maltose absorption test does not predict allograft rejection of small bowel transplantation in FK 506 immunosuppressed pigs. (1994) (0)
[Acquired tumor "robustness" in the case of prostate cancer]. (2006) (0)
A SUCCESSFULLY TREATED CASE OF INFLAMMATORY RECURRENCE AFTER BREAST CONSERVING TREATMENT BY WEEKLY TRASTSUZUMAB-PACLITAXEL THERAPY (2003) (0)
[A case of inflammatory fibrosarcoma of the retroperitoneum]. (2001) (0)
erioperative Management of Hepatic Resection oward Zero Mortality and Morbidity : Analysis of 93 Consecutive Cases in a Single Institution (2010) (0)
PRELIMINARY TRIAL OF ENTECARVIR MONOTHERAPY AFTER CONVERSION FROM HEPATITIS B IMMUNOGLOBULIN AND LAMIVUDINE THERAPY IN LIVING DONOR LIVER TRANSPLANTATION FOR CHRONIC HEPATITIS B INFECTION: 187 (2008) (0)
Transplantation in Patients with Previous Portasystemic Shunt (2010) (0)
OUTCOME OF HUNDRED FIVE CASES OF LIVING DONOR LIVER TRANSPLANTATION IN ADULTS AND CHILDREN: A SINGLE CENTER EXPERIENCE (2004) (0)
THE UW SOLUTION FOR CANINE KIDNEY PRESERVATION (2010) (0)
Studies of the Hepatotrophlc Qualities of FK 506 and eyA (2010) (0)
THE AVAILABILITY OF PREOPERATIVE 3D-CT STUDIES IN LIVING DONOR LIVER TRANSPLANTATION (2004) (0)
A CASE OF MASTECTOMY FOR BREAST CANCER WITH RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA UNDER GENERAL ANESTHESIA (2011) (0)
The pathology of the liver grafts after liver/small bowel or multivisceral transplantation (1995) (0)
[Evaluation of low-dose FP therapy as adjuvant therapy for gastric cancer]. (2005) (0)
Thoracoscopic microwave coagulation therapy for hepatocellular carcinoma at the dome of the liver : three case reports (2003) (0)
Interleukin-6 ) Monitoring in Liver Transplantation Focusmg on Allograft Rejection : A Five-Case Report (2010) (0)
Comparison of superoxide dismutase, allopurinol, co-enzyme Q10, and glutathione for the prevention of warm ischemic injury in rat livers (1990) (0)
A CASE OF CHYLOUS FISTULA AFTER RIGHT MASTECTOMY WHICH WAS TREATED CONSERVATIVELY (2010) (0)
A Case of Hepatocellular Carcinoma Resected by Right Trisegmentectomy with Hepatic Vein Reconstruction using Synthetic Graft (2007) (0)
DHMEQ, a New NF-kappa B Inhibitor, Suppresses Innate and Subsequent Allo-Immune Responses, and Permits a Long-Term Allogeneic Islet Engraftment Together with Tacrolimus (2010) (0)
[Eelctron microscopic observation on the etiology of cholesterosis of the gallbladder]. (1974) (0)
M1759 A Novel Anti-Inflammatory Agent, Dtcm-Glutarimide, Attenuates Experimental Colitis in Mice (2010) (0)
USE OF FK 506 IN THE TREATMENT OF UVER AllOGRAFf REJECI (2010) (0)
COMBINATION OF CTLA4IGG AND FTY720 SUPPRESSES DEVELOPMENT OF OBLITERATIVE BRONCHIOLITIS AND RESPIRATORY EPITHELIAL INJURY IN A MURINE HETEROTOPIC AIRWAY MODEL (1999) (0)
CHANGES OF THE PROTEIN BINDING OF TACROLIMUS AND THE PLASMA ALPHA-1-ACID GLYCOPROTEIN CONCENTRATION IN LIVER TRANSPLANT RECIPIENTS: 1599 (2010) (0)
IMPORTANT CHARACTERISTICS OF HEAVY WATER (D2O) CONTAINING COLD PRESERVATION SOLUTION: 3181 (2010) (0)
Instructions for use Title The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curativetreatment in patients with hepatocellular carcinoma (2017) (0)
An automated and portable low‐flow pulsatile petfusion system for organ preservation (1996) (0)
VEGF DRIVEN INTERPLAY OF INFLAMMATION AND PRIMITIVE CAPILLARY ANGIOGENESIS IN CHRONICALLY REJECTING (2006) (0)
LONG-TERM HEPATIC ALLOGRAFT ACCEPTANCE MEDIATED BY A NOVEL HUMAN ANTI-CD40 MONOCLONAL ANTIBODY, ASKP1240 (4D11), IN A NON-HUMAN PRIMATE: 431 (2010) (0)
IMMUNOHISTOCHEMICAL CHARACTERISTICS OF APOCRINE CARCINOMA OF THE BREAST (2005) (0)
TREATMENT FOR HEPATITIS C RECURRENCE IN LIVING DONOR LIVER TRANSPLANTATION (2004) (0)
[Structural study of black pigment gallstones]. (1977) (0)
Instructions for use Title Analysis of the risk factors for early death due to disease recurrence or progression within 1 year afterhepatectomy in patients with hepatocellular carcinoma (2017) (0)
A Fully Novel Human Anti-CD40 Monoclonal Antibody, 4D11 (ASKP1240), Renders Allo-Antigen Stimulated CD4+T Cells To Acquire Immuno-Regulatory Function (2010) (0)
Liver allograft pathology in liver/small bowel or multivisceral recipients. (1996) (0)
Which liver-disease patients need a transplant? (1988) (0)
FK 506 in small bowel transplant recipients (1994) (0)
A NOVEL NF-KAPPA B INHIBITOR, DHMEQ, ATTENUATES ARTERIAL VASCULOPATHY.: 470 (2008) (0)
Effect of Xanthine Oxidase System on Cold Inshemia-reperfusion Injury of the Canine Small Intestine (1995) (0)
PHYSIOLOGIC EFFECTS OF ORGAN PRESERVATION TECHNIQUES DURING LIVER TRANSPLANTATION (1989) (0)
Effect of preservation and transplantation on neuromuscular transmission in canine and human ileal smooth muscle (1992) (0)
Orthotopic liver transplantation in U.S. veterans under primary tacrolimus immunosupression. (1996) (0)
Elevated immunoreactive trypsinogen levels in pediatric patients with short bowel syndrome. (1998) (0)
Early experience with FK 506 in liver transplantation (1991) (0)
[Efficacy and toxicity of combination treatment with epirubicin (EPI) plus docetaxel (DOC) in advanced breast cancer]. (2006) (0)
6644 A novel NF-kB inhibitor DHMEQ suppressed peritoneal dissemination of pancreatic cancer in mouse xenograft model (2009) (0)
CORRELATION OF SERUM c-erbB-2 PROTEIN LEVEL WITH THE PROGNOSIS IN PATIENTS WITH PRIMARY BREAST CANCER (2001) (0)
[Indication and system of living-related and cadaver liver transplantation in Japan]. (2000) (0)
A NOVEL HUMAN ANTI-CD40 MONOCLONAL ANTIBODY, 4D11, FOR LIVER TRANSPLANTATION IN NON-HUMAN PRIMATE.: 191 (2008) (0)
[Various factors contributing to the development of liver transplantation]. (1998) (0)
Small bowel transplantation : from experimental to clinical (1992) (0)
CLINICAL INTESTINAL TRANSPLANTATION: RISK FACTORS AND NEW STRATEGIES (1998) (0)
‘Enteral brake’ mechanism ameliorated diarrhea after canine small bowel autotransplantation (1995) (0)
INDICATION OF PREOPERATIVE LIVER BIOPSY IN DONOR EVALUATION FOR LIVING DONOR LIVER TRANSPLANTATION: 1305 (2008) (0)
A Case of Spontaneous Rupture of Bile Duct Cystadenocarcinoma Associated with Sigmoid Colon Cancer (2007) (0)
USEFULLNESS OF CONTRAST-ENHANCED ULTRASONOGRAPHY IN THE PREOPERATIVE DIAGNOSIS OF GALLBLADDER CARCINOMA WITH GALLBLADDER ADENOMYOMATOSIS (2010) (0)
A CASE OF LAPAROSCOPIC CHOLECYSTECTOMY FOR INCIDENTAL CARCINOMA OF THE GALLBLADDER WITH PORTAL RECURRENCE 5 YEARS AFTER THE OPERATION (2008) (0)
in a Mouse Mammary Epithelial Cell Line NMuMG by Using cDNA Microarray DEK and Proto-oncogene Cyclin B 1-regulated Genes that Include ING 1 Identification of the p 33 Updated (2002) (0)
Immunologic and clinical effects of personalized selection of peptide vaccines in HLA-A2 positive patients with advanced cancer (2008) (0)
Original Contributions Transplantation of Multiple Abdominal Viscera (2010) (0)
A rescue case of an idiopathic cecum perforation accompanied with sub-acute fulminant hepatitis (2004) (0)
TWO CASES OF HEPATOCELLULAR CARCINOMA WITH OBSTRUCTIVE JAUNDICE DUE TO BILIARY INVASION (2010) (0)
Phenotype changes on peripheral blood lymphocytes in liver transplant recipients immunosuppressed by FK 506 (1992) (0)
ADENOSINE A1 RECEPTOR ANTAGONIST ATTENUATES ISCHEMIA-REPERFUSION INJURY OF THE LIVER (1999) (0)
Characteristics of graft-versus-host disease after Lewis-to-brown-Norway rat small bowel transplantation. (1994) (0)
Naturally Occurring Mutants Found inHuman Neuroblastomas COOH-Terminal Region of p 73 Which Is Impaired in the Identification of a Transactivation Activity in the Updated Version (1999) (0)
[A successful case of S-1 chemotherapy for bilateral pulmonary recurrence of hepatocellular carcinoma long after hepatectomy]. (2010) (0)
INHIBITION OF NF-KAPPA B AND/OR NFAT ACTIVATION AUGMENTS OR ABROGATES IMMUNOMODULATORY EFFECTS OF DONOR SPECIFIC TRANSFUSION.: 50 (2008) (0)
LONG TERM LIVER GRAFT ACCEPTANCE WITH AN NOVEL ADENOVIRUS MEDIATED CD40IgG GENE TRANSFER ON RAT.: Abstract# 643 (2000) (0)
Effect of Endogenous Adenosine Augmentation by Dipyridamole on Ischemia and Reperfusion Injury of the Liver. (1999) (0)
Canine Orthotopic Liver Transplantation Treated with a Novel Immunosuppresant, FTY720, and subtherapeutic doses of conventional drugs. (1999) (0)
HEAVY WATER CONTAINING ORGAN PRESERVATION SOLUTION, DSOL, AMELIORATES GRAFT SURVIVAL AND FUNCTION OF THE RAT HEARTS AFTER EXTENDED COLD PRESERVATION: 1562 (2010) (0)
TWO CASES OF METAPLASTIC BREAST CARCINOMA (2008) (0)
Optimal Curative Treatment For Early-Stage Hepatocellular Carcinoma: Hepatectomy Or Radiofrequency Ablation (2010) (0)
Tacrolimus ( FK 506 ) and the Pharmaceuticall Academid Regulatory Gauntlet (2010) (0)
A CASE REPORT OF PAPILLARY THYROID CARCINOMA WITH A GIANT CYST REMAINING FOR 24 YEARS (2007) (0)
PROTECTIVE EFFECT OF PROTEASE INHIBITOR, NAFAMOSTAT MESILATE(FUT-175), ON ISCHEMIA REPERFUSION INJURY IN CANINE LIVER. (1999) (0)
Clinicopathological Features and Surgical Results of Hepatocellular Carcinoma under 2cm in Diameter (2006) (0)
THE EFFECTS OF DHMEQ, A NOBEL NF-KAPPA B INHIBITOR ON DEVELOPMENT OF OBLITERATIVE BRONCHIOLITIS IN HETEROTOPIC MURINE AIRWAY ALLO- TRANSPLANTATION: 1950 (2008) (0)
A CASE OF BREAST CARCINOMA WITH OSTEOCLAST-LIKE GIANT CELLS (2002) (0)
PROGNOSTIC FACTORS AFFECTING THE SURVIVAL AFTER RECURRENCE OF BREAST CANCER (2002) (0)
TOTAL PANCREATECTOMY FOR DIABETES INDUCTION IN CYNOMOLGUS MONKEYS: 522 (2010) (0)
DTCM-GLUTARIMIDE, A NEW ACTIVATOR PROTEIN-1 (AP-1) INHIBITOR AMELIORATES TRANSPLANT VASCULOPATHY IN MICE: 1242 (2010) (0)
INTESTINAL TRANSPLANTATION IN CHILDREN – 5 YEAR EXPERIENCE (1995) (0)
Recurrence of primary squamous cell carcinoma of the ileum diagnosed by elevation of serum SCC: report of a case (2012) (0)
A Case of Hepatocellular Carcinoma with Long-time Survival by Successful Surgical Management of Metachronous Lung and Bilateral Adrenal Metastasis (2005) (0)
Cold preservation of the lluman colon and ileum with University of Wisconsin solution (2010) (0)
INHIBITION OF TYPE II PHOSPHOLIPASE A2 BY LY‐329722 ATTENUATES ISCHEMIA‐REPERFUSION INJURY OF THE LIVER.: Abstract# 1014 (2000) (0)
Th eNove lNF- BInhibitor ,Dehydroxymethylepoxyquinomicin ,Prevents Loca lan dRemot eOrga nInjur yFollowin gIntestinal Ischemia/Reperfusio ni nRats (2008) (0)
Long-term efficacy of intestinal transplantation in patients with end stage gastrointestinal failure (1998) (0)
Role of Postischemic Treatment with U-74500A for Prevention of Ischemia and Reperfusion Injury of the Canine Liver (1998) (0)
Venous-right atrial bypass for superior vena cava stenosis during orthotopic liver transplant (1997) (0)
ROLE OF CYCLIC NUCLEOTIDE REGULATION IN THE PREVENTION OF ISCHEMIA AND REPERFUSION INJURY OF THE LIVER.: Abstract# 1012 (2000) (0)
PAPILLARY THYROID CARCINOMA OCCURRED IN IDENTICAL TWINS AT THE SAME TIME (2003) (0)
Donor-Type Myelodysplastic Syndrome with t(2;3) and Monosomy 7 after Allogeneic Peripheral Blood Stem Cell Transplantation and Liver Transplantation in a Patient with Severe-Type Aplastic Anemia. (2006) (0)
SUCCESSFUL ISLET TRANSPLANTATION FROM A SINGLE-DONOR BASED ON CD40-CD154 COSTIMULATION BLOCKADE PLUS NF-κB INHIBITION: 1048 (2010) (0)
ELEVATION OF cyclic AMP AND cyclic GMP LEVELS BY PHOSPHODIESTERASE3 (PDE3) INHIBITOR ATTENUATES ISCHEMIA AND REPERFUSION INJURY OF CANINE LIVERS. (1999) (0)
Transluminal ligation of bleeding angiodysplasia of the small bowel without need for surgical resection (1993) (0)
The latest advances in liver transplantation at the pittsburgh transplantation institute: evolution of FK506, liver-intestinal transplantation, clinical xenotransplantation, and the induction of graft acceptance. (1994) (0)
[Recent progress in liver transplantation]. (2002) (0)
[Comparative studies of paclitaxel injection "SAWAI" and Taxol® Injection on pharmacokinetics in dogs and in vitro/vivo antitumor activities]. (2010) (0)
Organ transplantation (WS-076) Chairpersons: Susumu Ikehara, Jorge Kalil (2010) (0)
Injuriousness of glycochenodeoxycholate and taurochenodeoxycholate to cultured hepatocytes (2002) (0)
Functional and ultrastructural changes of mucosa in rat small bowel after cold ischemia (1994) (0)
PERMISSIVE LIMIT OF GRAFT SIZE FOR SUCCESSFUL LIVING DONOR LIVER TRANSPLANTATION IN ADULTS.: Abstract# 781 Poster Board #‐Session: P38‐III (2000) (0)
M1742 A Novel NF-κB Inhibitor, DHMEQ, Ameliorates Inflammatory Colonic Injuries in Mice (2010) (0)
Novel anti-inflammatory agent 3-[(dodecylthiocarbonyl)-methyl]-glutarimide ameliorates murine models of inflammatory bowel disease (2011) (0)
[Liver transplantation for patients with hepatitis B/C virus cirrhosis or hepato cellular carcinoma]. (2002) (0)
A CASE REPORT OF INVASIVE LOBULAR CARCINOMA OF THE BREAST WITH GASTRIC AND OVARIAN METASTASES (2002) (0)
Intestinal transplantation. (1994) (0)
INHIBITION OF THROMBOXANE A2 SYNTHETASE BY OKY-046 ATTENUATES ISCHEMIA AND REPERFUSION INJURY OF CANINE LIVERS (1998) (0)
[Successful treatment of ectopic insulinoma. Report of a case (author's transl)]. (1979) (0)
HEAVY WATER CONTAINING SOLUTION REDUCES INJURY OF GRAFTS SUBJECTED TO EXTENDED COLD PRESERVATION IN AN ISOLATED PERFUSED RAT LIVER MODEL: 1611 (2010) (0)
An Cnusual Complication of Choledochocholedochostomy in Orthotopic Liver Transplantation (2010) (0)
RISK FACTORS FOR THE OUTCOME OF 76 ADULTS UNDERGOING LIVING DONOR LIVER TRANSPLANTATION (2004) (0)
Successful Repeat Local Resection for Abdominal Wall Metastasis in Hepatocellular Carcinoma: A Case Report (2011) (0)
ELASTOSONOGRAPHY OF 72 BREAST LESIONS (2009) (0)
Adult Living Related Liver Transplantation: Indication and Strategy (1999) (0)
A Real-Time Immunological Monitoring in Living Related Liver Transplant Recipients.: Abstract# B789 (2014) (0)
Effect of a Novel immunosuppressant, FTY720, on Canine Renal Allograft. (1999) (0)
A RESECTED CASE OF RETROPERITONEAL GANGLIONEUROMA (2009) (0)
The effect of anti-complement agent K76 COOH on hamster and guinea pig to rat heart xenotransplantation (1996) (0)
A Role for Apheresis in Liver Transplantation for Hepatocellular Carcinoma : Anti-Viral Therapy Using a Double Filtration Plasmapheresis in Patients with Hepatitis C (2009) (0)
M1656 Effect of a Novel NF-κB Inhibitor, DHMEQ, On Dextran Sulfate Sodium-Induced Colitis in Mice (2009) (0)
THE NOVEL NF-∼ ÈB INHIBITOR, DEHYDROXYMETHYLEPOXYQUINOMICIN (DHMEQ) PREVENTS LOCAL AND REMOTE ORGAN INJURY FOLLOWING INTESTINAL ISCHEMIA/REPERFUSION IN RATS: 1688 (2008) (0)
6635 A novel NF-kB inhibitor DHMEQ could suppress peritoneal dissemination of gastric cancer by anti-tumor/-adhesive effects in mice (2009) (0)
[Thymidine phosphorylase as a prognostic factors of breast cancers]. (2000) (0)
MULTIDISCIPLINARY APPROACH FOR PATIENTS WITH FULMINANT HEPATIC FAILURE IN THE ERA OF LIVING DONOR LIVER TRANSPLANTATION: 824 (2008) (0)
Xenotransplantation: principles and practice (1996) (0)
Recent Advances in Hepatic Transplantation at (1993) (0)
Reply: Transient portocaval shunt for a small‐for‐size graft in living donor liver transplantation (2008) (0)
Liver xenotransplantation. (1993) (0)
The Immune Monitoring for Operationally Tolerant Recipients Following a Regulatory T cell-based Cell Therapy (2018) (0)
EFFECTS OF HEPATIC CYP3A4 ACTIVITY ON DISPOSITION OF SIRORIMUSU IN LIVER TRANSPLANT RECIPIENT: 2024 (2008) (0)
A Case of Sandifer's Syndrome (1998) (0)
Role of cyclic nucleotides in ischemia and reperfusion injury of canine livers1 (2002) (0)
IMMUNOSUPPRESSION BY A HUMAN ANTI-CD40 MAB, 4D11, IS NOT ABROGATED WHEN COMBINED WITH TACROLIMUS ON CYNOMORGUS MONKEY RENAL TRANSPLANTATION.: 190 (2008) (0)
A case report of late-onset hepatic vein stenosis after pediatric living donor retransplantation treated with balloon dilation (2013) (0)
COMBINATION THERAPY OF CTLA4IG AND FTY720 COMPLETELY PREVENT THE DEVELOPMENT OF OBLITERATIVE BRONCHIOLITIS AND RESPIRATORY EPITHERIAL INJURY IN A MURINE AIRWAY MODEL.: Abstract# 728 (2000) (0)
Orthothpic liver transplantation in US veterans under primary tacrolimus (PrografΓäó) immunosuppression (1996) (0)
TWO CASES OF RECURRENT THYROID PAPILLARY CARCINOMA OF WHICH METASTATIC LYMPH NODES WERE REMOVED ALONG WITH THE COMMON CAROTID ARTERY (2004) (0)
Abstracts Of Selected Papers Presented at the 32nd Annual Meeting of the Japanese Society of Gastroenterology (2007) (0)
Alterations in donor small bowel neuromuscular transmission with preservation time using University of Wisconsin solution. (1994) (0)
The Positive Rates of HLA-class-I Antigen in the Patients with Gastric Cancer Based on Immunohistochemical Staining (2007) (0)
Immunomodulation Induced By a Novel Immunosuppressant, NK026680 Plus Donor Specific Transfusion Permits a Long-Term Cardiac Allograft Survival in Mice.: Abstract# A68 (2014) (0)
The effect of FK 506 on spontaneous diabetes in the BB rat (1990) (0)
ANALYSIS OF RISK FACTOR FOR ATELECTASIS AND THE EFFECT OF PRONE POSITION THERAPY AFTER LIVING DONOR LIVER TRANSPLANTATION: 2035 (2008) (0)
PHYLLODES TUMORS OF THE BREAST: 3 CASE REPORTS WITH DYNAMIC MRI AND IMMUNOHISTOCHEMICAL STAINING (2004) (0)
Hydrogen Sulfide Confers Protection Against Hepatic Warm Ischemia Reperfusion Injury in Mice: 1911 (2012) (0)
ISOLATED INTESTINAL TRANSPLANTATION (ISBTx) IN CHILDREN: A REAPPRAISAL: 125 (1997) (0)
855 IMPORTANCE OF STAT3 AND PDK1/AKT PATHWAYS IN LIVER REGENERATION IN A MOUSE HEPATECTOMY MODEL: ROLES OF CELL PROLIFERATION AND SIZE (2009) (0)
Effects of immunosuppressive macrolides and nucleotide synthetase inhibitors on proliferation of lymphoid cells induced via distinct signal transduction pathways (1991) (0)
Species-Specific CycJosporine Metabolism (2010) (0)
A CASE REPORT OF THE MALIGNANT PHYLLODES TUMOR OF THE BREAST WITH ELEVATED SERUM CEA LEVEL (2001) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Satoru Todo?

Satoru Todo is affiliated with the following schools:

Satoru Todo's Academic­Influence.com Rankings

Satoru Todo's Degrees

Why Is Satoru Todo Influential?

Satoru Todo's Published Works

Published Works

What Schools Are Affiliated With Satoru Todo?

Satoru Todo's AcademicInfluence.com Rankings